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Abstract
Multiple Sclerosis is a common disease, affecting 2.5 million people world-wide. The
clinical course is heterogeneous, ranging from benign disease in which patients live
an almost normal life to severe and devastating disease that may shorten life.
Despite much research, a fully effective treatment for MS is still unavailable and
diagnostic techniques for monitoring MS disease evolution are much needed.

As a non-invasive tool, Magnetic resonance imaging (MRI) plays a key role in MS
diagnosis. Numerous MRI techniques have been proposed over the years. Among
most widely used are conventional T1-weighted (T1W), T2-weighted (T2W) and
FLuid Attenuated Inversion Recovery (FLAIR) imaging techniques. However their
results do not correlate well with neurological findings. Several advanced MRI
techniques are also used as research tools to study MS. Among them are
magnetization transfer contrast imaging (MT), MR spectroscopy (MRS), and
Diffusion Tensor Imaging (DTI) but they have not penetrated to clinical arena yet.

Gradient Echo Plural Contrast Imaging (GEPCI) developed in our laboratory is a
post processing technique based on multi-echo gradient echo sequence. It offers
basic contrasts such as T1W images and T2* maps obtained from magnitude of
GEPCI signal, and frequency maps obtained from GEPCI signal phase.
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Phase information of Gradient Echo MR signal has recently attracted much
attention of the MR community since it manifests superior gray matter/ white matter
contrast and sub-cortical contrast, especially at high field (7 T) MRI. However the
nature of this contrast is under intense debates. Our group proposed a theoretical
framework - Generalized Lorentzian Approach - which emphasizes that, contrary to
a common-sense intuition, phase contrast in brain tissue is not directly proportional
to the tissue bulk magnetic susceptibility but is rather determined by the
geometrical arrangement of brain tissue components (lipids, proteins, iron, etc.) at
the cellular and sub-cellular levels - brain tissue “magnetic architecture”. In this
thesis we have provide first direct prove of this hypothesis by measurement of
phase contrast in isolated optic nerve. We have also provided first quantitative
measurements of the contribution to phase contrast from the water-macromolecule
exchange effect. Based on our measurement in protein solutions, we demonstrated
that the magnitude of exchange effect is 1/2 of susceptibility effect and to the
opposite sign.

GEPCI technique also offers a scoring method for monitoring Multiple Sclerosis
based on the quantitative T2* maps generated from magnitude information of
gradient echo signal. Herein we demonstrated a strong agreement between GEPCI
quantitative scores and traditional lesion load assessment. We also established a
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correlation between GEPCI scores and clinical tests for MS patients. We showed
that this correlation is stronger than that found between traditional lesion load and
clinical tests. Such studies will be carried out for longer period and on MS subjects
with broader range of disease severity in the future.

We have also demonstrated that the magnitude and phase information available
from GEPCI experiment can be combined in multiple ways to generate novel
contrasts that can help with visualization of neurological brain abnormalities beyond
Multiple Sclerosis.

In summary, in this study, we 1) propose novel contrasts for GEPCI from its basic
images; 2) investigate the biophysical mechanisms behind phase contrast; 3)
evaluate the benefits of quantitative T2* map offered by GEPCI in monitoring
disease of Multiple Sclerosis by comparing GEPCI results to clinical standard
techniques; 4) apply our theoretical framework - Generalized Lorentzian Approach
– to better understand phase contrast in MS lesions.
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Chapter 1 Introduction

1.1 Nuclear Magnetic Resonance Imaging
Magnetic Resonance Imaging (MRI), or nuclear magnetic resonance imaging, is a
medical imaging technique used extensively to visualize detailed internal structures
of the body. MRI makes uses of the property of nuclear magnetic resonance (NMR)
to image (most commonly 1H in H 2 O) nuclei inside the body. The content in this
section (1.1) can be found in most classical textbooks on the subject (1,2).

1.1.1 Nuclear Spin
Spin is the intrinsic quantum property of nucleons. The overall spin of the nucleus is
determined by the spin quantum number S. The spin of a proton, which is the most
common signal source in MRI experiment, is 1/2. That means proton has two
possible spin states m = 1/2 or m = -1/2 (also referred to as spin-up or spin-down).
When placed in a magnetic field, there are only two energy eigenstates, one
representing alignment parallel to the field, another anti-parallel. The population
ratio of the two states is determined by several factors as shown below:

Population( anti − parallel )
−µ B
)
∝ exp(
Population( parallel )
kT
where µ is magnetic moment of the spin, B is external magnetic field strength, k is
the Boltzmann constant and T is the absolute temperature. Majority of spin
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[1.1]

population goes to the lower energy state. Note that with in vivo biological samples
that we are interested in (physiologic temperature) and with commonly available
magnets, there is only a slight population difference between two energy states –
on the order of 1 in a million spins. Fortunately, in biological samples we have huge
population of 1H (55 Molar), which provides a sufficient signal.

In the field of magnetic resonance, for convenience in describing mechanism of
signal generation (which is coming not from single spin but from object comprised
of millions of spins), spins are usually analogued in the context of classical physics.
Just as a spinning top precesses around the gravitational field, nuclear spin
precesses around the magnetic field. The frequency of this precession is called
Larmor frequency ω0= γ ⋅ B0 , which is proportional to the strength of magnetic field
B 0 , and γ - the gyromagnetic ratio.

1.1.2 Free Induction Decay
After nuclear spins are polarized under external magnetic field, they reach
equilibrium, and result in a net magnetization along the B 0 field. Upon excitation
with a 90° pulse (radiofrequency (RF) pulse), which is perpendicular to the
magnetic field, the spins are forced to precess in the transverse x,y plane. A
receiver coil is positioned in the transverse plane to pick up the current generated
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by the precessing magnetization, which is subsequently amplified and becomes
NMR signal.

B0
Precession
plane

Spin
magnetization

Figure 1.1 Illustration of spin precession.

The NMR signal, known as free induction decay or FID, decays over time (usually
on the order of 10-1 - 10-2 s in human tissue). Because microscopic sources of
magnetic fields including electron magnetic moment and electron orbital currents,
and also the nucleus itself, create their own local surrounding field, and also
because of atomic motions, any nucleus in a sample will experience a net magnetic
field whose direction and strength is fluctuating with time. As a result, all individual
nuclei precess at slightly different frequencies. They get out of phase with each
other over time, causing decay of the macroscopic magnetization.
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B0

B0
‘in phase’

Precession
plane

wait for some time

‘dephase’
Precession
plane

Spin
magnetization

y receiver

Spin
magnetization

y receiver

x

x

Mxy

time

Figure 1.2 Illustration of Free Induction Decay.

1.1.3 Imaging Basics – Gradient and K-space

Applied magnetic field gradients are essential in Magnetic Resonance Imaging
experiments. A constant field gradient results in magnetic field with a linear
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dependence on position. For example, a gradient in the x-direction, Gx , when
applied in addition to a uniform field B 0 , gives a spatially dependent field

B = B0 + x ⋅ Gx ; and this field results in a spatially dependent Larmor frequency

ω = ω0 + γ ⋅ x ⋅ Gx . In this way, the location of a nucleus can be tracked by its
precession frequency, by x =

(ω − ω0 )
. This technique of spatial encoding also
γ Gx

known as frequency encoding results in a one-dimensional projection of spin
density (as shown in Figure 1.1, 1.2 and 1.3). In practice, a gradient of equal
magnitude, opposite direction, and half duration is applied before the frequency
encoding gradient to form a gradient echo. The MR signal collected during the
presence of frequency encoding (read-out) gradient around gradient echo time
(See Figure 1.4 Illustration of gradient echo sequence diagram.Figure 1.4).

Figure 1.3 Illustration of frequency encoding.
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A two-dimensional image is created with the so called 'phase encoding gradient'
applied in orthogonal direction to the frequency encoding gradient. Phase encoding
is accomplished by applying an orthogonal gradient after the RF pulse and before
the frequency encoding gradient for a short period (typically on the order of
millisecond). This phase encoding gradient will cause the spins to accumulate
certain amount of position-dependent phase in its direction. In an imaging
experiment, the data collected at the gradient echo formed by the frequency
encoding gradient constitutes a single line of 'k-space'. A full k-space is composed
of multiple lines of k-space (typically 64,128 or 256 for convenience of Fast-FourierTransform), each line collected with a different phase encoding gradient strength. In
case of 2D imaging, raw data (k-space) is the 2D Fourier transform of the target
MR object. Inverse Fourier transform is applied to the k-space data in order to
obtain corresponding real space image.

1.1.4 Gradient Echo Sequence
An example of imaging pulse sequence - gradient echo sequence (the most
important one for our project) is shown below for the 2D version.

6

Figure 1.4 Illustration of gradient echo sequence diagram.

Frequency selective RF pulse (usually a small flip angle rather than 90o) is
applied in the presence of Gradient along the slice direction, that will excite the
spins in a targeting slice.
Followed by a rewinding gradient in the slice direction, which drives back the
dephasing of spins caused by the slice-select gradient.
In the phase encode direction, a gradient is applied over certain duration, so
that spins along this direction will accumulate position-dependent phase.
In the frequency encode direction (or read out direction), a pre-rewind gradient
which has power of exactly half of the read-out gradient is applied. It can be
followed by a delay time before the readout gradient is turned on, which will refocus
the spins in readout direction at gradient echo time TE (Time of Echo).
A gradient echo is formed when the spins in the readout direction are pulled
back in phase. Receiver is turned on during readout gradient to collect signal.
The time between RF pulse and the echo is called Gradient Echo time. The
7

time delay between two excitation RF pulses is called TR: time of repetition.
Within one TR, one k space line is collected.
During repetitive TRs, everything is carried out the same way except that
phase encode gradient varies from time to time, allowing collection of different k
space lines.

1.2 Complex MR signal

y

M
ϕ
x

Figure 1.5 Illustration of MR signal components.

The signal that we measure in MRI is a complex number. It can always be written
as A ⋅ e − iϕ , where A is the magnitude of signal, that represent signal strength, and

ϕ is the phase of signal, that characterizes rotational evolution of nuclear
magnetization overtime.
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Over years most MRI research and applications were directed to searching for
information from the magnitude of signal. It can be weighted by different signal
decay mechanisms by carefully designed pulse sequences. Pulse sequences
based on contrast mechanisms such as T1, T2, spin density, FLAIR, diffusion,
magnetization transfer, etc., are now commercially available from most MRI
manufactures.

The phase information of Gradient Echo MRI signal has recently attracted much
attention of the MR community. Part of the reason why people did not consider
phase information useful is because field variations at all different scales will affect
signal phase, and these variations are not only due to intrinsic properties of sample,
but largely affected by environmental factors (anything that will affect field
homogeneity). However, since It manifests superior gray matter/ white matter
contrast and sub-cortical contrast at high field (7 T) (3), and it is extremely easy to
obtain – by simple gradient echo sequence, it has become a hot topic in the field of
MRI in recent years. However, the nature of phase contrast is under intense
debates. By studying properties of protein solutions and rat optical nerve (as model
systems) our group has contributed to deciphering the main mechanisms
contributing to the phase contrast. This will be discussed in Chapters 2 and 3.
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1.3 Multiple Sclerosis
Multiple sclerosis (MS) is a common disease, affecting 2.5 million people worldwide. The clinical course is heterogeneous, ranging from benign disease in which
patients live an almost normal life to severe and devastating disease that may
shorten life. Despite much research, a fully effective treatment for MS is still
unavailable.

There are three subtypes of MS, classified according to their patterns of
progression (4-6). 1) Relapsing-Remitting (RRMS), characterized by unpredictable
relapses followed by months to years of relatively quiet periods with no signs of
disease activity before another relapse. It is the majority of MS population (8590%), and is the only clinical subtype that responds well to current immunomodulatory drugs (IMDs). 2) Secondary-Progressive (SPMS) evolves from over
50% of RRMS cases. Patients entering this stage will begin to have progressive
neurologic decline between acute attacks. 3) Primary Progressive (PPMS) occurs
in about 10% of MS patients. In this case patients have a steady neurologic decline
with superimposed attacks from onset.

Symptoms of MS patients are very diverse. It can be almost any neurological
symptoms, including changes in sensation, muscle weakness, difficulty moving,
difficulties with coordination and balance, problems in speech or swallowing, visual
10

problems, fatigue, acute or chronic pain, and bladder and bowel dysfunctions.
Cognitive impairment of varying degrees and emotional symptoms of depression of
unstable mood are also common. The main clinical measure of disability
progression and symptom severity is the Expanded Disability Status Scale
(EDSS)(7).

Cause of MS is not definite. It is likely to occur as a result of some combination of
genetic, environmental and infectious factors (4), and possibly other factors like
vascular problems (8).

The pathology of this disease is rather complex - many processes co-exist in the
CNS (e.g. inflammation, demyelination, axonal damage and repair mechanisms).
Inflammatory CNS demyelination with relative preservation of axons has been
considered the pathologic hallmark of MS, but it has been known for many years
that axonal loss also frequently occurs in MS (9,10). In principle, the functional
deficits in MS caused by inflammation and demyelination can be reversible. In
contrast, the damage to axons and neurons is likely to be irreversible.

Complexity of MS and lack of clinical diagnostic tools capable of identifying different
specific aspects of MS stimulate numerous investigators to continue search for new
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diagnostic methods. Especially important is a problem of early diagnostic as much
accumulating data indicate that early treatment is beneficial to decrease ultimate
disability in MS (11).

1.4 Magnetic Resonance Imaging in MS
As a non-invasive tool, Magnetic resonance imaging (MRI) plays a key role in MS
diagnosis (12,13). Numerous MRI techniques have been proposed over the years.
Among most widely used are conventional T1-weighted (T1W), T2-weighted (T2W)
and FLuid Attenuated Inversion Recovery (FLAIR) imaging techniques.

Figure 1.6 Example of clinical standard MRI used for monitoring MS (obtained in
our laboratory). a) T1-weighted image, b) T2-weighted image, c) FLAIR.

As shown in Figure 1.6, in T2W image, WM appears dark, and CSF appears bright,
with GM in between of them. MS lesions show heterogenous intensity between WM
and CSF, but are always brighter than WM – so called hyperintense appearance. In
FLAIR images CSF signal is suppressed, so that lesions are visually more
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detectable. This is most frequently used in clinical scans in MS subjects. In T1W
image on the other hand, WM demonstrates itself as bright, and GM as gray, CSF
as dark gray. MS lesions that show up on T2w images do not always came out on
T1w image. Those that show up on T1w as hypointense are often called blackholes or grey-holes, indicating severer tissue damage than those that are not seen
on T1w. This is the only conventional sequence that provides information about the
severity of the MS lesion

T1w SE

T1w SE (Gd)

Figure 1.7 Example of clinical standard MRI used for monitoring MS. left: T1weighted spin echo image; right: T1w-SE image with Gd-enhancement.

T1w image is also used for detecting ‘active lesions’, where administration of
gadolinium (Gd) based contrast agent is needed. Because Gd shortens T1
relaxation time constant, the T1w image post-contrast will immediately have
brighter blood vessels. Thus if there is a leak in blood-brain barrier (BBB), Gd will
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find its way in brain tissue – lesion area – and the lesion will light up as ‘enhanced
lesions’. Since BBB breakdown allows immune cells to infiltrate in the brain tissue,
causing the known demyelination (14), the Gd-enhanced lesions are often referred
to as ‘active lesions’.

The volume of T2W lesions is often used as a secondary endpoint in clinical trials,
but it does not correlate well with MS disability (11). This is due to multiple factors,
including not only inherent imaging limitations, but also that volumetric measures
do not take into consideration lesion locations which determine the functional
systems affected, do not include most gray matter lesions. This paradox has been
attributed to the complexity and heterogeneity of the underlying tissue damage in
MS, to the different effects on function caused by different lesion locations, as well
as to variable degrees of neural plasticity among patients. Lack of strong
correlation between clinical findings and standard imaging is especially noted in the
progressive clinical subtypes (15,16), the subtype where effective treatments are
most needed. Indeed, a “plateau effect” between T2W lesion volume and disability
has been reported after MS disability reaches a certain level (15,16). Better
quantitative imaging is particularly urgently needed for evaluation of new therapies
for progressive MS subtypes in a timely fashion(17,18).
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Several advanced MRI techniques are also used as research tools to study MS.
Among them are magnetization transfer contrast imaging (MT), MR spectroscopy
(MRS), and Diffusion Tensor Imaging (DTI).

MT

measures

the

exchange

of

nuclear

magnetization

between

bound

(macromolecular associated) and free (mobile) water 1H in tissue (19,20). Following
selective saturation of the pool of bound 1H using a radiofrequency pulse, the
image intensity of mobile 1H 2 O is reduced due to the magnetization exchange
process. The ratio of MR signal intensities of selectively saturated vs. nonsaturated experiments, defined as magnetization transfer ratio (MTR) changes with
loss of myelin and axons in MS and can be used as a measure of MS pathology
(21,22), and correlates inversely with disability (23). Thus far, MT has not been
widely used except in research studies. MTR would be difficult to use as a
surrogate endpoint in multi-center trials due to site-to-site differences.

Another imaging method used primarily in research studies to assess underlying
pathology in individual MS lesions is MR spectroscopy (MRS). In CNS, in vivo 1H
MRS measures the presence and relative amounts of various tissue metabolites
such as N-acetylaspartate (24), choline, creatine, etc. (25). Because NAA derives
almost exclusively from mature axons and neurons (9), its persistent reduction is
considered a specific indicator of axon loss, damage, or dysfunction. Moreover,
reduced NAA is found in the NAWM of some relapsing-remitting (RRMS),
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secondary progressive (SPMS), and primary progressive (PPMS) MS patients (26),
and the degree of reduction may differentiate SPMS from RRMS (27). Overall, NAA
appears to be a meaningful neuroimaging marker for evaluating MS pathology,
specifically axonal injury (28,29). However, MRS suffers from long acquisition time,
coarse spatial resolution limiting its sensitivity and universal applicability.

Diffusion Tensor Imaging (DTI) provides quantitative data on the rate and direction
of water diffusion (30). DTI has the potential to identify and differentiate axon
loss/injury from demyelination, as shown in several animal model studies (31-35).
The major limiting issue with DTI at present is that it is still labor-intensive to obtain
high quality quantitative data routinely.

So far, amongst the best of the correlations between standard imaging methods
and clinical function occurs with chronic T1W hypointensities. The volume of T1W
hypointensities, or “black holes,” correlates, albeit modestly, with disability
(11,16,18). The better correlation between “black holes” volumes and disability is
likely because chronic MS lesions that are hypointense on T1W have more axon
loss than those that are not (18,36). However, even the determination of what
constitutes a “black hole” is subjective and non-quantitative. There are degrees of
“blackness” of T1W hypointense lesion. Just because two “black holes” may
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occupy the same volume doesn’t mean they have the same severity of underlying
pathology.

The image contrast in the standard “weighted” spin-echo sequences depends not
only on the MR relaxation time constants of the brain tissue but also on the
parameters of the pulse sequence. This non-biological dependence may lead to an
incorrect estimation of the black hole load, as lesions may not be apparent when
image contrast is poor. These shortcomings can be overcome by using recentlyproposed approaches based on measuring tissue T2 and T1 relaxation times
instead of using T2- and T1-weighted images(37,38). Based on published data, this
would also allow improved differentiation among types of MS pathologies.
Importantly, a recent study in autopsied MS brain tissue showed good correlation
between T1 and T2 relaxation time constants and MS pathology (38). Correlations
with another imaging measure, magnetization transfer ratio, MTR were not as
strong. These new findings opened a door for using MRI relaxation time constants
as quantitative markers of tissue damage in MS. However, the proposed
quantitative methods (37,38) are not practical, even for clinical trials, because of
the long time needed to produce accurate quantitative T1 and T2 maps.

GEPCI technique developed in our laboratory (39-41) can aid in solving this
problem and differentiate the degree of “blackness” by quantitatively measuring
17

tissue T2* relaxation time constant in a clinical acceptable time (< 8 min). It offers a
scoring method for monitoring Multiple Sclerosis based on the quantitative T2*
maps generated from magnitude information of gradient echo signal. Herein we
demonstrated a strong agreement between GEPCI quantitative scores and
traditional lesion load assessment. We also established a correlation between
GEPCI scores and clinical tests for MS patients. We showed that this correlation is
stronger than that found between traditional lesion load and clinical tests. Such
studies will be carried out for longer period and on MS subjects with broader range
of disease severity in the future.

1.5 Dissertation Overview

Chapter 2 and Chapter 3 focus on studying the biophysical mechanism behind
phase contrast in brain tissue. Experiments are carried out on carefully designed
model systems.

Chapter 2 deals with magnetic susceptibility effects. The theory of correctly relating
susceptibility to the frequency shift that we measure is proposed. Validation
experiments in silico as well as ex vivo are described in this chapter.

Chapter 3 is about the relative magnitude of susceptibility effect mentioned in the
previous chapter and the exchange effect which also shifts MR frequency. The
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experimental setup that allows clean separation of these two effects is described;
experimental results and validation experiment of this method are also presented in
detail.

Chapter 4, Chapter 5 and Chapter 6 brings our investigation in vivo, which include
both healthy volunteers and MS subjects.

Chapter 4 lays out all the experimental considerations in GEPCI technique involved
in the following chapters. The first section describes the parameter optimization;
model of the signal is discussed in the second section, multiple derived contrasts
from GEPCI technique are also included in this chapter.

Chapter 5 presents the method for implementing GEPCI technique to assist with
evaluation of the MS disease. Quantitative tissue damage score is introduced,
applied to MS subjects. Comparison between GEPCI measurement and clinical
standard evaluations is performed.

Chapter 6 presents the application of the theory described in chapter 2 to the MS
disease. It made the effort of bridging understanding of MR signal frequency to the
pathology of MS. MS abnormalities on phase images are identified. And theoretical
explanation of data and its relationship to corresponding pathology is presented.
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Chapter 7 closes out the dissertation by summarizing the specific accomplishments
of this study, and also proposes several interesting future directions beyond this
study.

[
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Chapter 2 Biophysical Mechanism behind MR Signal
Phase – Susceptibility effect 1

2.1 Introduction
Phase MR images obtained by gradient-recalled echo protocols provide greatly
enhanced contrast in the brain at high magnetic fields (3,42-45), which allows
visualization of biological structures within gray matter (GM) (46) and white matter
(WM) that are distinct from conventional T1-weighted and T2-weighted images.
However, the biophysical origin(s) of the phase (frequency) contrast is not well
understood, and has been ascribed to a variety of phenomena: (i) susceptibility
effects induced by differing tissue chemical composition, specifically including
differences in iron (47-49), deoxyhemoglobin (50,51), proteins (52,53), and myelin
content (54); (ii) magnetization exchange effects between “free” water and
macromolecules (42,55,56) and (iii) possible anisotropy of tissue magnetic
susceptibility (57,58). A role for myelin was suggested by a report demonstrating
that demyelination leads to a loss of phase contrast between WM and GM (54,59).
It has also been shown that the phase contrast between WM and cortex can be
principally

attributed

to

variations

in

myelin

content

(60).

However

in

contradistinction phase contrast is very small between WM, a myelin rich structure,

1

Part of contents in this chapter have been published in Luo J, He X, Yablonskiy DA. Magnetic susceptibility

induced MR Signal frequency shift in white matter. Proc. Int. Soc. Magn. Reson. Med. 2012; 415.
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and cerebrospinal fluid (CSF) where myelin is essentially absent (3,61). To explain
this curious phenomenon, He and Yablonskiy (61) introduced a new theoretical
concept called the Generalized Lorentzian approach. An important insight from this
conceptual framework is that the local contribution to the MRI signal phase does
not depend solely on the bulk magnetic susceptibility of the tissue, but also on the
“magnetic architecture” of the tissue – i.e., the distribution of magnetic susceptibility
inclusions (lipids, proteins, iron, etc) at the cellular and sub-cellular levels. This
theory explained why phase contrast is essentially absent between WM and CSF
and provided a conceptual platform for quantitative interpretation of data from MR
phase imaging of white matter diseases.

Herein the of “Generalized Lorentzian” concept is validated using ex vivo rat optic
nerve as a model system. Representative of pure white matter, the simple
geometry of isolated optic nerve provides a well-defined cylindrical shape that
minimizes global magnetic field distortions and contamination from neighboring
tissues.

2.2 Theory

2.2.1 Magnetic Susceptibility
Magnetic susceptibility describes how a substance reacts to the presence of
external magnetic field B . M= χ ⋅ B . M is magnetization defined as a substance
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magnetic moment per unit volume. There are three different kind of materials
categorized according to their reaction to magnetic field: paramagnetic,
diamagnetic,

and

magnetically

ordered

substances

(ferromagnetic,

anti-

ferromagnetic and ferrites).

Paramagnetic substances usually have unpaired electrons and positive χ on the
order of 10-3 at room temperature Their M has the same sign as B. Diamagnetic
substances have no unpaired electrons their χ is 10-3 smaller than paramagnetic
substance – it is on the order of ppm, and it is negative - M has an opposite sign
compared to B. In magnetically ordered substances unpaired electrons are aligned
with respect to each other and their magnetic susceptibility can be several orders of
magnitude bigger than in paramagnets.

As it comes to human brain tissue that we are interested in, majority of the mass is
diamagnetic, such as water, lipids, proteins. Iron (Fe2+ or Fe3+) on the other hand is
paramagnetic. Since there is only trace amount of iron (usually about 10-5 g/g wet),
overall magnetic susceptibility of brain tissue is negative. It is not surprising to find
that as complex structure as brain, its susceptibility is not homogenous. For

χ m ⋅ B which is
example myelin with susceptibility of χ m , has magnetization M=
m
different from magnetization of surrounding substances and will create additional
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magnetic field upon itself and surrounding cytosol environment, resulting in an
inhomogenous magnetic field at the cellular and subcellular levels.

Since signal phase is often thought of as directly related to magnetic field
distribution, the variations of susceptibility of brain tissue, although small, plays a
very important role in the phase contrast that we observe in the brain. To unveil the
relationship between the tissue susceptibility and signal phase that we measure,
we need to answer two questions: 1) what is field b in the tissue area, and 2) what
is the relationship between b field and MR signal phase?

2.2.2 The signal phase that we measure

B0

Water
molecule
Susceptibility
sources

Figure 2.1 Schematic of water molecule moving around surrounding susceptibility
sources.
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In brain imaging, MRI signal coming from a given voxel is the sum of all signals
generated by nuclei in the specific voxel.

=
S (t )

∑ exp(−iϕ (t ))

[2.1]

n

n

As drawn in Figure 2.1 there are multiple susceptibility inclusions in the voxel –
lipids, proteins, iron (all marked with blue dots). Water molecule (green dot) is
moving around them all the time due to diffusion. So phase accumulated by single
nucleus should be expressed by the integral of b field felt by this water molecule



through the trajectory over time. b( r ) at each given point is affected by all of its
surrounding susceptibility inclusions. Since water molecules that are within
characteristic diffusion distance (about 1µm) sample experience more or less the
same environment, their signal phase can be expressed as proportional to < b > .

One way to find < b > is called ‘Lorentzian Sphere Approach’. It borrows the idea
proposed by Lorenz (1901), that < b > can be considered as a sum of < b > far and

< b > near - two parts separated by an imaginary sphere (demo in Figure 2.2).
Lorentz HA. The Theory of Electrons. 1909

< b >=
< b > near + < b > far

+

=
< b > near =
0

< b >=
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4
π ⋅ χ ⋅ B0 + SF ⋅ χ ⋅ B0
3

Figure 2.2 Schematic of Lorentzian Sphere Approach.
Due to diffusion and the fact that average field outside a dipole is zero, the < b > near
field is zero. The < b > far on the other hand (since all the susceptibility inclusions
are far away from the nuclei of interest) can be seen as a field generated by a
homogenous media. Thus < b > depends on two things: 1. Lorentzian factor, that is
a spherical boundary with vacuum on the inside and susceptibility χ on the
outside; 2. The Shape Factor, which varies from different global shapes of the
whole object. For example, if global shape of object is also a sphere, then Shape
factor will be ( −4 / 3)π , if it is an infinitely long cylinder, SF will be −2π ⋅ sin 2 α .

Frequency shift ∆f

due to the presence of external magnetic field can be

expressed as a sum of two terms (62). First term describes effects of global shape
of the sample:

∆f
f0

= SF ⋅ χ

[2.2]

shape

and the second term describes the short-range, structure specific effects (i.e.,
dependent upon the specific spatial arrangement of magnetic particles/dipoles) and
is generally referred to as the contribution from Lorentzian sphere:

∆f 4
π ⋅χ
=
f0 3
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[2.3]

Here f 0 is the base Larmor frequency, χ is the volume magnetic susceptibility of
the liquid sample, and SF is a shape factor dependent on a global shape of the
object.

The Generalized Lorentzian Approach (He and Yablonskiy) adds a very important
consideration to the Lorentzian Sphere Approach – symmetry of the tissue
microscopic structure. It says that if tissue has very regular architecture that has a
scale much larger than the characteristic distance of water diffusion, then the
selection of lorentzian cavity needs to be modified based on the actual
arrangement of macromolecule/susceptibility inclusions. Particularly in the brain
white matter, the axons have very specific geometry. A large amount of magnetic
inclusions are aligned along axonal direction such as neurofilaments, and myelin
sheath. Some can run for cm’s long. When doing separation of < b > near and

< b > far as we did before, we need to choose our Lorentz cavity as a cylinder. Then
Lorenz factor will be −2π ⋅ sin 2 α , and shape factor depends on brain geometry on
the macroscopic level.

2.2.3 Frequency shift of MRI signal in a solution surrounding optic
nerve:
The magnetic susceptibility of the nerve is comprised of magnetic susceptibility of
longitudinal components/structures χ L and magnetic susceptibility of isotropic
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components/structures χ iso .The homogeneous medium surrounding the nerve has
magnetic susceptibility χ e . In the imaging plane which presents a cross-sectional
view of the nerve in the NMR tube, the nerve-induced frequency shift ∆f e / f 0
experienced by the homogeneous medium outside the nerve is described by the
well-known equation as follows:

∆f e
f0

r > r0

r
= 2π ⋅ ( χ iso + χ L − χ e ) ⋅ ( 0 ) 2 ⋅ cos(2θ ) ⋅ sin 2 α
r

The frequency shift is proportional to the bulk (total) magnetic susceptibility
difference between the nerve ( χ iso + χ L ) and the surrounding solution ( χ e ). Moving
radially away from the nerve, the frequency shift decays as 1 / r 2 , r0 is the radius of
the nerve. The angular dependence of the pattern of the frequency shift in the MR
imaging slice plane is described by the angle θ between coordinate of interest in
the plane and the projection of magnetic field B 0 onto plane (Figure 2.3); α is the
angle between B 0 and long axis of the nerve. When α = 0° , the nerve is parallel to
B 0 , there should be no frequency shift in the homogeneous medium outside the
nerve; whereas when α= 90° , the frequency shift effect is maximal. Integrating
over all angles θ , the average frequency shift induced by the nerve on the external
medium is zero.
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[2.4]

Figure 2.3 Illustration of the secondary field, generated by the optic nerve when B 0
is perpendicular to the axis of the nerve Eq. [2.4].

2.2.4 Frequency shift of MRI signal between inside the nerve and the
outside solution surrounding optic nerve
When B 0 field is parallel to the long axis of the nerve, the global shape factor SF =
0 (long cylinder approximation), and the optic nerve frequency shift induced by the
longitudinal structures within the nerve is equal to zero (Eq. [2.2] : Lorentzian
cylinder). In this case, the only frequency shift observed between inside the nerve
and the external homogeneous medium ∆f i −e / f 0 is that induced by the isotropic
components,

4
π ⋅ ( χ iso − χ e ) per Lorentzian sphere, Eq. [2.3]. In the case when B 0
3

forms an angle with the long axis of the sample, the global shape factor

SF =
−2π ⋅ ( χ iso + χ L − χ e ) ⋅ sin 2 α , the Lorentzian cylinder contribution of the intranerve longitudinal structures is = 2π ⋅ χ L ⋅ sin 2 α , and the Lorentzian sphere
contribution of isotropic structures is still

4
π ⋅ ( χ iso − χ e ) . Including a possible
3

macromolecule exchange effect (which would not depend on the angle between the
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long axis of the nerve and B 0 ) (42,55), the average frequency shift ∆f i −e / f 0
between inside the nerve and the homogeneous external medium (per Eq. [2.4] the
average field induced by the nerve itself in the surrounding media is zero) is:

∆f i −e
4
=
−2π ⋅ ( χ iso − χ e ) ⋅ sin 2 α + π ⋅ ( χ iso − χ e ) + MWE
f0
3

[2.5]

A very important feature of Eqs [2.4] and [2.5] is the difference in their dependence
on magnetic susceptibility: while Eq. [2.4] depends on the total magnetic
susceptibility of the optical nerve ( χ iso + χ L ), Eq. [2.5] depends only on the isotropic
component χ iso (longitudinal structures do not contribute to the frequency shift in
circular structures)! This would not be the case in a traditional use of the Lorentzian
sphere approach where both Eqs. [2.4] and [2.5] would depend on the total
magnetic susceptibility ( χ iso + χ L ).

2.3 Materials and Methods

2.3.1 Materials
Pairs of rat optic nerves are harvested from three euthanized rats (SpragueDawley). For each subject, one nerve was soaked in 1% PBS buffer, and examined
2~3 hours after death. The other nerve was subsequently fixed with 10% formalin,
and examined 1~2 days later.
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Two pieces of thin coated copper wires (30 micron diameter) were used to tie the
optic nerve at both ends. The [wire-nerve-wire] structure was then threaded through
an NMR tube with two open ends. The free ends of the copper wires are then
wrapped around both ends of the NMR tube (2.97 mm ID), with the nerve
suspending in the middle of the tube (as shown in Figure 2.4). The NMR tube was
filled with either 1% PBS or 10% formalin fixative, and sealed tight with parafilm.

Figure 2.4 Picture of the experimental setup.

2.3.2 MRI Procedures:
Experiments were performed on an Angilent/Varian DirectDriveTM MR scanner
based on a 4.7-T horizontal-bore superconducting magnet with a 21 cm diameter
inner bore gradient and shim assembly, using a 1.5 cm diameter, laboratory
constructed, surface transmit/receive RF coil. Localized shimming employed a
STEAM sequence on a 5 x 5 x 5 mm3 voxel, selected at the mid-point of the optic
nerve’s longitudinal length. Typical linewidth ~ 8 Hz (range 5 to 12 Hz) was
achieved. Data were acquired using a multi-echo gradient echo sequence, on a 1mm thick slice with 75 x 75 µm2 in plane resolution. TR 170 ms, first TE 7.4 ms,
echo spacing 13.176 ms, flip angle 30 deg, imaging matrix 128 x 128, total
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acquisition time 17 min (with 50 averages). The tube was first oriented parallel to
B 0 and then rotated 6 times by ~15 degree each time until a perpendicular
orientation was reached. Following each rotation, (i) the exact orientation of each
rotation was determined from scout images; (ii) the imaging plane of the multi-echo
gradient echo sequence was oriented perpendicular to the optic nerve; (iii) localized
shimming was performed to minimize field distortions. (Note that if the optic nerve
and NMR tube were not perfectly parallel, then imaging plane was made sure to be
perpendicular to the nerve.) Experiments were repeated three times on each pair of
optical nerves.

2.3.3 Data processing
Data were processed with Matlab® software (The MathWorks, Inc.). Eight fold
zero-filling was applied to k-space data in order to increase digital resolution for
more accurate estimation of optic nerve radius r0 . Then the data were Fourier
transformed into imaging domain (63) and a Hanning filter was applied to reduce
Gibbs-ringing and signal leakage.

Frequency maps f

were determined from phase maps ϕ corresponding to

different gradient echo times TE according to equation ϕ = ϕ 0 + 2π ⋅ f ⋅ TE . Phase
unwrapping was preliminary performed in the time-domain for each voxel as
described in (39).
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Evaluation of the optical nerve position and radius:

Knowledge of the radius r0 of the optic nerve is required to determine the magnetic
susceptibility of the optic nerve as per Eq. [2.4]. To find the center of the optic nerve
and subsequently measure its radius, a map of the image intensity gradient was
generated based on the magnitude image I(x,y), Eq. [2.6]:

G ( x, =
y)

[ I ( x + 1, y ) − I ( x − 1, y )]2 + [ I ( x, y + 1) − I ( x, y − 1)]2

where x and y are voxel coordinates in the imaging plane. Starting from an initial
estimate of the nerve’s center coordinate (origin), radial rays were traced across
and covering the nerve’s full circumference at 2° intervals (i.e., 180 rays in total).
Coordinates of maximal ray intensity (maximal image gradient) at each 2°
increment outline the first estimate of the edge of the optic nerve. An updated
estimate of the nerve’s center was found by averaging coordinates of the edge
points and the entire process was repeated until convergence was achieved.
Finally, r0 was determined by calculating average distance from the center point to
all the edge points.

2.3.4 Field inhomogeneity correction
Before determining the susceptibility of the optic nerve based on the frequency
maps, account must be taken of the background field inhomogeneities. This was
done by expanding the angular dependence of the frequency map in terms of a
Fourier series:
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[2.6]

f ( r, θ=
) f 0 ( r ) + ∑ cos( n ⋅ θ ) ⋅ f nc ( r ) + ∑ sin( n ⋅ θ ) ⋅ f ns ( r )

[2.7]

where θ is the azimuthal angle, n=1,2,… and r is the distance from the nerve
center (Figure 1). The coefficients in this series can be expressed in a standard
manner:

1
f ns ( r ) =
∫ f (r,θ ) ⋅ sin(nθ )dθ ;

π

1
f nc ( r ) =
∫ f (r,θ ) ⋅ cos(nθ )dθ ;

π

1
f0 (r) =
∫ f ( r , θ )dθ ;
2π 

[2.8]
All coefficients in front of the harmonics can be further expressed as Taylor series:

=
fn (r)

∑a

nm

⋅ rm

[2.9]

where m=0,1,2,… The only exception to this expression is the f 2 c ( r ) term is
associated with cos(2θ ) because the field generated by the optical nerve also
contains the term cos(2θ ) , Eq. [2.4], hence this term should be written as

f 2 c (=
r)

∑a

2m

⋅ r m + 2π ( χ iso + χ L − χ e ) ⋅ sin 2 α ⋅ r02 ⋅ r −2

[2.10]

As the dipolar term is proportional to 1 / r 2 , when one is close to the inner cylinder
(the minimum point) the local field is mainly affected by this term, while at larger r ,
distant from the inner cylinder, the field inhomogeneity plays bigger role. The f ( r )
curves are first calculated by numerical integration of frequency maps for the
distant regions ( r > 2 r0 ) according to Eqs. [2.8]. Then coefficients a nm are
calculated by fitting Eqs. [2.9] and [2.10] to these curves. Finally, fitting results are
used to calculate all terms in Eq. [2.7] (usually up to second order) for all r and θ ;
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the frequency maps are subsequently corrected by subtracting these terms except
for the term cos(2θ ) ⋅ f 2 c ( r ) .

2.3.5 Evaluation of imaging errors
In-silico experiments - computer simulations of the MRI experiment were conducted
to evaluate errors in parameter estimates that might have been introduced by the
imaging protocol itself. All programs for data generation and analysis were written
in Matlab®. Imaging protocol parameters in the simulations were set to reproduce
experimentally employed parameters. 2D in-silico imaging data mimicked crosssectional slices of two infinitely long co-axial cylinders filled with different
homogenous media.

The inner cylinder had radius r 0 = 0.32 mm, corresponding to the optic nerve, and
the outer cylinder had radius R = 1.87 mm, corresponding to the NMR tube. The
field of view was 9.6x9.6 mm2 and the matrix size was 128 x128. The k-space
sampling of the object was calculated according to the following equation:

(k x , k y )
S=

∫ ∫ ρ ( x, y ) ⋅ exp(−i ⋅ 2π ⋅ (k

x

⋅ x + k y ⋅ y ) + i ⋅ γ ⋅ b( x, y ) ⋅ (TE + t )) ⋅ dxdy [2.11]

where TE is the gradient echo time, t is time during readout ( 2π k x = −γ Gx t ), γ is
the gyromagnetic ratio and b(x,y) is the secondary field generated by the
susceptibility difference ( ∆χ i −e ) between the different homogeneous medium
assumed to fill the inner and outer cylinders. This susceptibility difference was set
according to a preliminary evaluation measurement: ∆χ i −e = - 9.287 ppb. In
simulations, b(x,y) inside the inner cylinder was described by the Lorentzian sphere
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approach, in this case requiring shape factor of cylinder and Lorentzian factor of
sphere, hence b(x,y) = −(2 / 3)π ⋅ ∆χ i −e ⋅ B0 . The field surrounding the inner cylinder
(present in the annulus between the two concentric tubes) is b(x,y) =

r
2π ⋅ ∆χ i −e ⋅ ( 0 ) 2 ⋅ cos(2θ ) ⋅ B0 . To focus on magnetic susceptibility effects the global
r
field inhomogeneity was neglected and the T2 relaxation time constant was
assumed to be infinite for both compartments. The integral in Eq. [2.11] was
calculated as a discrete sum over 2048 x 2048 points which is 16x16 times greater
than the simulated imaging resolution (128 x128).

Effects of different data processing procedures, such as zero filling and Hanning
filtering were evaluated with cylinders perpendicular to B 0 . Different combinations
of spin densities of inner and outer cylinders (in:out) were selected as 1:2, 2:1, 3:2
and 2:3, bracketing that observed in actual experiments. Finally, the specific TE,
image intensity, and b field corresponding to experimental data presented in
Results were used to estimate r0 from simulated data with B 0 parallel to the axis of
the concentric cylinders. These results were subsequently used for correction of the

r0 estimated from experimental data.

2.3.6 Determination of Magnetic Susceptibility
The bulk magnetic susceptibility of the nerve was determined following field
−2
inhomogeneity correction using Eq. [2.10]. Fitting f 2 c ( r ) against r yields the
2
2
coefficient 2π ( χ iso + χ L − χ e ) ⋅ r0 ⋅ sin α , which is then fit to a linear function of
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sin 2 α to yield 2π ( χ iso + χ L − χ e ) ⋅ r02 . Since r0 is known from measurements
described above, the bulk (total) susceptibility ( χ iso + χ L − χ e ) is obtained.

The frequency shift experienced in the interior of the inner cylinder or optic nerve
vs.

surrounding

homogeneous-medium

was

also

determined

after

field

inhomogeneity correction. The average frequency shift experienced by the
surrounding medium is zero. The frequency shift experienced in the interior of the
inner cylinder or optic nerve is calculated by averaging over the area inside the
cylinder/nerve (an area around the center point covering less than half of the
cylinder/nerve diameter to avoid partial volume effects).

2.4 Results

2.4.1 In Silico Experiments
2) with b field, created by the susceptibility effect

1) Simulation results without b field
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Figure 2.5 An illustration of in silico results and procedure for determining radius of
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the inner cylinder (input value: 35 pixels). Left panel - results without including
susceptibility effect in the simulation; Right panel - results with susceptibility effect.
a,a' - objects created for simulation; b,b' - original magnitude images obtained from
simulated data; c,c' - magnitude images obtained after zero filling and Hanning
filter; d,d' - field maps used in simulations; e,e' - original phase images obtained
from simulated data; f,f' - phase images obtained after zero filling and Hanning
filter; g,g' - gradient maps of the magnitude of the processed image (c,c'
respectively); h,h' - plots of radius vs. sample points around the cross-section of the
inner cylinder.

Two examples of the results of in-silico experiment are shown in Figure 2.5. Limited
imaging resolution, partial volume effects, and Gibbs ringing artifacts create
uncertainties in determining the inner cylinder radius. Even with no susceptibility
difference between the two compartments, the simulated data do not provide for an
exact determination of the radius of the inner cylinder. The different combinations of
spin densities showed the same effect (Table 2.1). In the presence of magneticsusceptibility-induced field inhomogeneities, the measured radius deviates more
from the true (input) r 0 , shown in Fig 2.5h’. Moreover, distortion of the cylinder is
demonstrated clearly in the plot of radius as measured at different angles about the
inner cylinder. This effect results from the static inhomogeneous b field, which adds
an additional gradient (although small) to the imaging gradient. Herein, since the
simulation employed a susceptibility difference between actual nerve tissue and
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surrounding solution that was close to the experimental value, it is possible to use
the in-silico results as correction factors in the processing of the experimental data.
Spin Density Ratio
(Inner : Outer)

Estimated r0

Estimated r0

at χ = 0

at χ = - 9.287 ppb

Deviation from
Input (%)

2:1
3:2
1:2
2:3

34.7070
34.7070
34.7070
34.7070

33.0829
32.1771
36.0424
36.7514

-5.4%
-8.0%
2.98%
5.01%

Table 2.1 In-silico measured radius of inner cylinder obtained for different 'spin
densities' (input radius is 35); simulation was performed with assuming the echo
time TE of 20 ms; both Hanning filter and zero filling were applied during data
processing.
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Figure 2.6 Example of the profiles of phase images obtained from in-silico data for
B 0 oriented perpendicular to the cylinder axis along the read out direction. The
frequency distribution arising in the simulation (Lorentzian sphere approach)
resulted from an assumed susceptibility for homogeneous medium in the inner
cylinder of χ = -9.287 ppb. Vertical scale is phase value in radians; Horizontal scale
is pixel number with origin at the center of inner cylinder. a) Profiles through the
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center of the inner cylinder along B 0 direction; b) Profiles through the center of the
inner cylinder perpendicular to B 0 direction. Solid black lines represent resulting
phase after simulation (processed with zero-filling and Hanning filter), blue dotted
lines represent the “ideal” phase result which is proportional to the input of
susceptibility induced b field.

Figure 2.6 shows phase distortions revealed by the in in-silico procedure, which
arise from magnetic susceptibility effects. Major deviations from the input model
parameter are seen at the edges of the inner cylinder. However the central portion
and the “tails” of frequency maps around the inner cylinder more closely follow the
ideal phase. In fitting in silico data to Eqs. [2.9] and [2.10], the data points to be
modeled are chosen be sufficiently far from the edge of the nerve so as to avoid the
distortions shown in Figure 2.6. For the case of B 0 perpendicular to the cylinder, the
frequency shift between the inner cylinder and the average frequency shift outside
of the inner cylinder is:

∆f i −e
2
= − π ⋅ ∆χ i −e . Considering only the central area of the
f0
3

inner cylinder (avoiding partial volume effects) yields ∆χ i −e = 9.2875 ppb which is
practically identical to the input parameter ∆χ i −e = - 9.2867 ppb. Considering the
frequency shift outside of the inner cylinder yields, Eq. [2.4], ∆χ i −e = 9.3023 ppb,
which differs from the input model parameter by only 0.016 ppb or 0.17%.

Spin Density Ratio
(Inner : Outer)

Fresh Optic
Nerve Mimic

Deviation
from Input
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Fixed Optic
Nerve Mimic

Deviation
from Input

3:2
1:2

(pixels)

(%)

(pixels)

(%)

34.5537
35.4734

-1.28%
1.35%

34.0043
36.7754

-2.84%
5.07%

Table 2.2 Examples of error in r0 measured when coaxial cylinders (inner and
outer) are parallel to B 0 . Input r0 was 35 pixels; b(x,y) inside inner cylinder was
modeled as having essentially the same frequency shifts as encountered in the
actual optic nerve experiments. Top row shows the cases when cylinder spin
density ratio inner : outer = 3 : 2, sampled at TE = 7 ms; Bottom row shows the
cases when spin density ratio inner : outer = 1 : 2, at TE = 25 ms.

2.4.2 Ex vivo experiments
Figure 2.7 demonstrates dependence of the signal phase inside the optical nerve
on gradient echo time TE. The data shows that the linearity of phase as function of
TE is very good (R2 >0.99), which means that a set of echo times used in our
experiments is not sensitive to the non-linear phase behavior observed in (64-66).
Figure 2.8 and Figure 2.9 show examples of magnitude and phase images
obtained from the optical nerve.
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Figure 2.7 Representative examples of signal phase evolution along echo time at
different angles (α) to B 0 . Experimental data.were taken from inside the optic nerve.
The phase at TE=0 was set to zero. The solid lines are linear fits. All four data sets
show good linearity.
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Figure 2.8 Illustration of the results of zero-filling and Hanning filtering of data.
Images shown are obtained while optic nerve is perpendicular to the B 0 direction.
Profiles through the center of the optic nerve are displayed. a) Profile directly
resulting from IFFT of k-space data. b) Profile after Hanning filter was applied to a)
to eliminate Gibbs ringing artifact. c) Profile after eight fold zero filling was applied
to b) to increase digital resolution. e) Profile after only eight fold zero filling was
applied to a), i.e., no Hanning filter. Magnitude and phase images corresponding to
cases a) and c) are displayed in d) and f), respectively.

9.8 Hz

- 9.8 Hz

Figure 2.9 An example of experimental data obtained from a fixed optic nerve.
Upper row - magnitude images, middle row - corresponding frequency maps, and
bottom row - frequency maps after field correction. Maps from left to right show
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cross-sections of the optic nerve as the nerve was rotated from parallel to B 0 to
perpendicular to B 0 in steps of 30 degrees.
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Figure 2.10 Example of the profiles of phase images after field correction. Profiles
are drawn through the center of the nerve. Vertical scale is value of phase in
radians, horizontal scale is pixel number in the image matrix. a) Profile along
readout direction when nerve is parallel to B 0 ; b) profile along phase encode
direction when nerve is parallel to B 0 ; c) profile along readout direction when nerve
is perpendicular to B 0 ; d) profile along phase encode direction when nerve is
perpendicular to B 0 .
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Field corrected profiles of the phase images for parallel and perpendicular cases
are displayed in Figure 2.10. Profiles are taken through the center of the nerve in
both horizontal and vertical directions. The frequency shifts described in Eq. [2.4]
are clearly demonstrated here. When the nerve is parallel to B 0 , it does not induce
frequency shift in the surrounding media, whereas when nerve is perpendicular to
B 0 , it induces maximal frequency shift to the surrounding that decays as 1/r2. In
agreement with theoretical prediction, the readout and phase encode directions
show frequency shift with opposite signs [as cos(2θ) changes from 1 to -1].

Magnetic Susceptibility Measurements
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Figure 2.11 Angular dependencies of the frequency shifts for one fresh nerve and
one fixed nerve. Filled circles - experimental data; lines - linear fits against sin 2 α .
Panels A) and C) are frequency shifts of inside nerve vs. surrounding media; B) and
D) are coefficients in front of ( r0 / r ) 2 in Eq. [2.10] describing frequency shifts
induced outside the nerve by magnetic susceptibility difference between nerve and
surrounding media.

2π ( χ iso + χ L − χ e )

Fitting Results [ppm]
Fresh
nerve

Rat 1
Rat 2
Rat 3
Average +/std
Rat 1
Rat 2
Rat 3
Average +/std

Fixed
nerve

R

2

2π ( χ iso − χ e ) MWE

-0.043
-0.050
-0.040
-0.044 ± 0.005

0.978
0.999
0.989

-0.021
-0.025
-0.0232
-0.023 ± 0.002

-0.062
-0.056
-0.049
-0.056 ± 0.006

0.997
0.998
0.995

-0.052
-0.049
-0.035
-0.045 ± 0.009

-0.003
0.002
-0.003
-0.001 ±
0.003
-0.017
-0.004
-0.013
-0.011 ±
0.007

R

2

0.99
0.98
0.91

0.99
0.99
0.97

Table 2.3 Summary of fitting results from three fresh and three fixed optical nerves
without correction to radii of optic nerves.
[ppb]

r0

Uncorrected
Fresh Optic Nerve
Fixed Optic Nerve
[ppb]

χ iso + χ L − χ e

χ iso − χ e

χL

χ e − χ w χ iso + χ L − χ w

-7.0 ± 0.8
-8.9 ± 1.0

-3.5 ± 0.3
-7.2 ± 1.4

-3.4 ± 0.7
-1.6 ± 0.6

-2.2
0

-9.2 ± 0.8
-8.9 ± 1.0

-7.0 ± 0.9
-9.6 ± 1.7

-3.5 ± 0.3
-7.2 ± 1.4

-3.3 ± 0.8
-1.9 ± 0.5

-2.2
0

-9.2 ± 0.9
-9.6 ± 1.7

r0

Corrected
Fresh Optic Nerve
Fixed Optic Nerve

Table 2.4 Summary of magnetic susceptibilities calculated from Table 2.3.
Numbers represent mean ± standard deviation.

After background field is removed, dependency of the frequency shifts on sin 2 α is
plotted in Figure 6. Fitting results from three data sets of both fresh nerves and
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fixed nerves are recorded in Table 2.3. If the Lorenzian sphere approximation
would be valid, the magnitude of the slopes in ∆f i −e / f 0 vs. sin 2 α plot and

∆f e / f 0 |r > r0 vs. sin 2 α plot would have been the same. As we can see, none of the
fresh nerve data agree with the prediction from the Lorentzian sphere
approximation. Hence Generalized Lorentzian approach should be applied to
explain our observations. For fresh nerve, the average result of 2π ( χ iso + χ L − χ e )
is (-0.044 ± 0.005) ppm, and 2π ( χ iso − χ e ) is (-0.023 ± 0.002) ppm. The
subsequently estimated χ iso − χ e and χ L are - (3.5±0.3) ppb and - (3.5±1.1) ppb,
respectively. Further, the linearity of fittings is good, which means that the sin 4 α
term, as proposed in (57) to describe the susceptibility anisotropy, is negligible in
our data. On the other hand, the magnetic susceptibility of longitudinal structures,

χ L , observed in fixed nerves is much smaller. Also note that the bulk susceptibility
difference between nerve and surrounding media is consistently different for fresh
nerve and fixed nerve by ~ 20%. This difference can be attributed to the difference
in experimental conditions – fixed nerves were studied in 10% formalin solution
while fresh nerves were studied in 1% PBS solution. To take into account these
differences we measured magnetic properties of formalin and PBS and results are
presented in section 2.6. While no measurable susceptibility difference between
formalin solution and water was found, the susceptibility difference between PBS
and water is - 2.2 ppb.
Finally, the intercept of plot ∆f i −e / f 0 vs. sin 2 α is equal to

4
π ⋅ ( χ iso − χ e ) + MWE
3

, Eq. [2.5], allows estimation of the water-macromolecule exchange effect in the
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optic nerve. Result shows that MWE in fresh nerve is negligible, while MWE in fixed
nerve is around 0.038 ± 0.007 ppm. These results however cannot be directly
attributed to water-macromolecule exchange inside the optical nerve. Indeed, data
in Appendix show that both formalin and PBS shift water frequency by nonsusceptibility mechanism.

Possible error introduced by the data processing procedure is investigated in the in
silico experiments. And a major source of error comes from image distortions as
demonstrated in Figure 2.5 and Figure 2.6, which has significant effect on the
measurement of radius of the optical nerve. If correct number for radius is used, the
error of resulting bulk susceptibility measurement is within 0.2%. Since the data we
use to fit curves described in Eqs. [2.9] and [2.10] are far away from the edge of
nerve, this step should not be affected by the imaging distortion at the edge of
nerve. And also according to Eq. [2.4], when nerve is parallel to B 0 , there will be no
additional field outside nerve, which indicate least asymmetric distortion. We
decided to correct the radius of nerve measured in parallel cases, and then use that
as 'real r 0 ' when calculating susceptibility. Corrections on r 0 are applied to
experimental data and reported for reference in Table 2.4.

On the other hand, measurement of susceptibility from inside of the nerve is
independent on the radius, and thus very accurate. Errors here might come from
the fact that the nerve tissue actually has more than one frequency
compartments(64-66). Though this effect is not apparent in our data, see Figure
2.7.
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2.5 Discussions
It is generally understood that the MRI signal frequency shift induced in biological
objects due to magnetic susceptibility effects is dependent on the objects bulk
magnetic susceptibility and shape. However, this is not adequate to explain
frequency shifts observed in brain white matter. For example, the Lorentzian
sphere approach predicts equal slope magnitudes comparing a plot of ∆f i −e / f 0 vs.

sin 2 α and a plot of ∆f e / f 0 =|r

r0=
,θ 0

vs. sin 2 α . The fresh nerve results presented

herein are clearly not in agreement with this prediction. The Generalized Lorentzian
Approach (61) proposed that the underlying microstructure of the object at the
cellular and sub-cellular levels should also be included in the model describing the
MR signal frequency shift. This is especially important for brain structures such as
white matter composed mainly from longitudinally arranged cells (i.e., neurons).
Demonstrating this phenomenon in the brain is highly challenging because of
complicated underlying structure and generally sufficient resolution of MRI
experiments. Herein, the MR signal frequency shift induced by a tract of white
matter was determined and compared to the predictions of two theoretical concepts
– Lorentzian sphere approach and the generalized Lorentzian approach (cylinder
model). The cylindrical geometry of isolated optic nerve, a tract of axonal bundles
running parallel to each other, provides a well-defined shape that minimizes
distortions in B 0 and eliminated contamination from neighboring tissues. These
attributes make it possible to accurately measure the bulk magnetic susceptibility of
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freshly harvested optic nerve ( χ iso + χ L − χ w =
−9.2 ± 0.8 ppb ) as well as the

−3.4 ± 0.7 ppb ).
longitudinal component ( χ L =

Quantitative measurement of frequency shifts is crucial for this study. Simulations
generating in silico image data were performed to test the bias of post-processing
procedures. As demonstrated in Figure 2.6, the transition point from inner cylinder
to outer cylinder is greatly affected by imaging resolution and also field distortions.
Similar profiles are also observed in ex vivo data (Figure 2.10). Moreover image
definition of the circular edge of inner cylinder can be distorted when the cylinder is
not parallel to B 0 (Figure 2.5h’). Fitting data outside the nerve substantially distant
from the transition point ( r > 2 r0 ) and then extrapolating the back to smaller r
avoids

this

artifact

and

provides

an

accurate

determination

of

2π ( χ iso + χ L − χ e ) ⋅ r02 ⋅ sin 2 α . Employing the exact r0 and α , the deviation
between the derived susceptibility and the ‘true value’ (model parameter value(s)
input to the simulation) is only 0.17%.

With this insight gained from the simulations, the radius r 0 of the nerve measured
with cylinder parallel to B 0 , was used in combination with simulation results in Table
2.2 to get “true r 0 ” when calculating susceptibility since Eq. [2.4] shows that when
the nerve is parallel to B 0 there will be no additional field outside the nerve and thus
the least asymmetric distortion. Experimental results on susceptibilities are reported
with and/or without corrections on r 0 in Table 2.4. Finally, although sin α
2
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determined each time the tube was rotated is, of course, not be perfectly accurate,
fitting to multiple measurements at 5 to 7 different values of α ensures the
accuracy of the final result. While the frequency shift inside of the nerve is, in
principle, independent of the nerve radius r0 , partial volume effects on the
measurement were avoided by evaluating only the area for which r < 2 r0 .

Effects of magnetization exchange might also be a significant factor in determining
the frequency shifts in the biological tissue (42, 55-56). In the experiments herein,
magnetization exchange will contribute to the frequency shifts separately from the
susceptibility effect. As magnetization exchange will not be dependent on the angle
formed between nerve tissue and B 0 , it enters Eq. [2.5] as a constant term. In
principle, these experiments should allow determination of the exchange effect, as
described in “Results”. These findings, however, cannot be directly attributed to
water-macromolecule exchange inside the optical nerve since data in the
“Appendix” show that both formalin and PBS shift the water MR frequency by nonsusceptibility mechanisms and the volume fraction of either formalin or PBS that
penetrates inside of the nerve is unknown.

A multiple compartment model has been proposed to explain the MR frequency
shifts between grey matter and white matter (64-66). The measurements obtained
from voxels inside the optic nerve would need to be reexamined if multiple
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frequency compartments were found to originate within one voxel. This
phenomenon does not appear to be significant (Figure 2.7) within the TE range that
used here.

Anisotropic susceptibility of white matter has also been proposed to explain MR
frequency shifts observed in white matter. Experimental data herein demonstrate
that the MR frequency shifts observed in optic nerve tracts can be fully described
by the generalized Lorentzian concept (Lorentzian cylinder model) in the absence
of postulating an anisotropic susceptibility for white matter.

2.6 Magnetic Susceptibility and Exchange Effects in External Media
Separate measurement of susceptibility and exchange effects were performed to
exclude the contribution from external media in our experimental setup. Since the
fresh nerve was measured while suspended in 1% PBS solution, and fixed nerve
was done in formalin.

NMR Experiments: This experiment applied the method for simultaneously
determining the susceptibility effect and exchange effect employed in a previous
publication (Luo et al.) details of experiments can be found there (or in Chapter 3).
A scheme employing coaxial tubes was employed. The inner tube (2mm outer
diameter) was filled with water and 0.5% Dioxane; the outer tube (5mm outer
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diameter) was filled with aqueous solutions containing either 1% PBS or 10%
formalin (exact same solutions that were used in optic nerve experiments),
including 0.5% Dioxane. MR experiments were conducted on a Varian INOVA 500MHz (11.74-T) vertical bore analytical spectrometer. Samples did not contain D 2 O,
which is commonly used for field/frequency locking and shimming. A separate
coaxial tube containing a D 2 O/H 2 O mixture was used for shimming (maximizing B 0
homogeneity). After shimming, the sample was loaded, and FIDs were collected.
Radiation damping was minimized by detuning the receiver coil and employing a
reduced filling factor (5 mm outer tube diameter in a RF coil greater than 10 mm in
diameter).

Results:
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Figure 2.12 Results for formalin measurement.

Figure 2.13 Results for PBS measurement.

As spectra in Figure 2.12 and Figure 2.13 show, the MR frequency near 3.6 ppm is
identified as dioxane and the peak near 4.7 ppm is identified as water. Regarding
neighbor resonances originating from the same 1H species, the resonance with
greater intensity is from species in the outer tube of the co-axial set, and the lower
intensity resonance is from species in the inner tube. Since the dioxane MR
frequency is considered reflective only of a susceptibility effect, the frequency shifts
between dioxane in the inner and outer tubes reflects the susceptibility deviation of
PBS or formalin solutions (here compared to pure water). Formalin did not induce
discernible frequency shift on dioxane resonances, whereas PBS induced a 0.0093 ppm shift compared to pure water. However, the 1H water MR resonance
frequency is affected not only by the susceptibility effect, but also by other effects pH, exchange with other labile protons, etc. Figure 2.12 shows that the principal
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formalin 1H resonance has a frequency shift induced by non-susceptibility effects of
+0.050 ppm. Figure 2.13 shows that the PBS solution has frequency shifts induced
by non-susceptibility effects of -0.013 ppm. These results are important factors to
consider when understanding the results of the current manuscript and other such
experiments in fixed tissue.

2.7 Conclusion

The Generalized Lorentzian Approach well-describes the MR frequency shifts in
white matter. Freshly harvested nerve and fixed nerve show quite different results
for the longitudinal component of susceptibility, which suggest that care should be
taken when analyzing phase data in fixed tissue and projecting findings to in vivo or
freshly excised tissues.

[
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Chapter 3 Biophysical Mechanism behind MR Signal
Phase – Exchange effect 2

3.1 Introduction
Gradient recalled echo (GRE) MR phase images acquired at high magnetic field
strength show remarkably enhanced contrast between gray matter (46) and white
matter (WM) in human (3) and animal (43) brain. The contrast-to-noise ratio in MR
phase images shows an almost 10-fold improvement over conventional MR
magnitude images. Anatomic/functional structures that are not apparent on
magnitude images can be visualized in phase images. Indeed, phase contrast has
been explored for applications such as the study of multiple sclerosis (67) and
Alzheimer’s disease (68). While the remarkable contrast observed at high field with
phase imaging is provocative, the biophysical origins of this contrast are poorly
understood. For example, phase variations have been observed across different
brain regions (3), in both healthy and diseased brains. To fully quantify the
anatomic, functional, and physiological information contained within phase images,
it is crucial to understand the biophysical underpinnings of the MR “phase image”
signal formation.

2

All contents in this chapter have been published in Luo J, He X, d’Avignon DA, Ackerman JJH, Yablonskiy DA.

Protein-induced water 1H MR frequency shifts: Contributions from Magnetic Susceptibility and Exchange. J. Magn.
Reson. 2010; 202:102-108.
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The MRI signal phase is determined by frequency shifts caused by multiple
effectors. One group of effects relates to magnetic susceptibility variations within
the tissue. Such tissue components as lipids (3), non-heme iron (3,69-71),
deoxyhemoglobin in the blood (3,49,72), and proteins (53,73) were suggested as
possible sources of susceptibility variation. Importantly, He and Yablonskiy (74)
showed that the MR signal frequency shift depends not only on tissue chemical
composition but also on tissue architecture at the cellular and subcellular levels
(i.e., geometrical distribution of cells and structures within the cells). They proposed
a new theoretical concept for evaluation of the frequency shifts that lead to tissue
phase contrast between GM/WM/CSF. Their theory provides a means to predict
tissue frequency shifts from the known tissue architecture and magnetic
susceptibilities of proteins, lipids, tissue iron and deoxyhemoglobin in the blood.
The derived shifts agree very well with the experimental results of Duyn et al. (3).
Importantly, the work by He and Yablonskiy successfully explained the lack of
phase contrast (3) between WM and CSF in the motor cortex area of the human
brain.

However, another mechanism - the water-macromolecule exchange effect - has
been suggested as an alternate or contributing cause of GM/WM phase image
contrast (42). The association of water and hydrophilic groups on the surface of
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macromolecules, including labile 1H sites, and resultant exchange between “bound”
and “free” water, is known to substantially contribute to the water 1H T 1 and T 2
relaxation times due to the abundant macromolecular content in vivo, especially
proteins

(75-79).

Although

a

water-macromolecule

association/exchange

mechanism cannot solely explain both the lack of contrast between CSF and WM
(3) (protein contents are different - 10.9% in WM (24) and 0.015%~0.045% in CSF
(80)) and the orientation dependence of phase contrast in white matter (43), it
remains important to assess the roles of exchange vs. susceptibility in the
formation of phase contrast.

Proteins constitute one of the major components of brain tissue (~50% of dry tissue
weight). Thus, it is reasonable to hypothesize that proteins could play a dual role –
modulating both magnetic susceptibility and water-macromolecule exchange - in
shifting the water MR frequency. Understanding the extent to which these roles are
in play is important to quantitative interpretation of the contrast in GRE phase MR
images. Hence, the major goal of this manuscript is to separate and scale the
contributions of protein-induced magnetic susceptibility and exchange effects to the
observed shifts in MR signal frequency.
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3.2 Materials and Methods
An aqueous solution of BSA (bovine serum albumin) was chosen as a model
system to study the effects of protein content on the water 1H MR signal frequency.
1,4-Dioxane ("Dioxane"), which has been reported to be an appropriate internal
reference in protein solutions (81), was employed as an internal 1H MR frequency
reference.

3.2.1 Sample preparation
To prepare a stock protein solution, 10g BSA (99% purity, Sigma, [CAS No. 904846-8]) was dissolved in de-ionized water (with 0.5% v/v Dioxane) to a final volume
100ml. The solution was clear to the eye, indicating the lack of residual insoluble
components. Additional BSA samples were prepared from this stock solution by
dilution with de-ionized water (which also contained 0.5% v/v Dioxane) to
concentrations of 25, 50, 75, 100 mg (BSA)/ml (solution). The BSA volume fraction
of the stock solution was calculated by weighing the volumetric flask before and
after making the solution; from the mass of the BSA powder and the mass of the
total solution, the mass of de-ionized water was determined. Knowing the density of
water at the relevant temperature, the water and BSA volume fractions were
derived.

3.2.2 Mechanisms Affecting the 1H Water MR Signal Frequency
The magnetic resonance frequency f of a spin immersed in a homogeneous
media containing macromolecules can be described by several additive
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γ ⋅ B0 , the base Larmor resonance frequency,
components: (i) a component f =
0
where γ is the gyromagnetic ratio and B 0 is the main static field, (cgs units are
used throughout this paper), (82) a component ∆f χ due to the magnetic
susceptibility of the media, (iii) a component ∆f e due to chemical exchange
between free (bulk) water and bound water, typically that associated with
hydrophilic groups on the surface (and perhaps interior) of macromolecules, and
(83) a component -σf 0 due to the local, electronic shielding provided by the “host”
water molecule (shielding factor σ):

f=

f 0 + ∆f χ + ∆f e − σ ⋅ f 0 .

[3.1]

The frequency component ∆f χ due to magnetic susceptibility for a homogeneous,
isotropic liquid (media) can be described as a sum of two terms. The first term
arises from the presence of the media’s external boundary:

∆f / f 0 =
A⋅ χ ,

[3.2]

where χ is the volume magnetic susceptibility of the media. Here for simplicity we
only consider media whose boundary can be described by an arbitrary ellipsoidal
shape. Hence, the magnetic field inside the boundary containing the media is
homogeneous with the factor A depending on the specific shape of the media
boundary (see the discussion in (62)). For example, if the media boundary forms an
infinitely long cylinder, oriented with angle θ between the cylinder's main axis and

4
3

B0, A =
−2π ⋅ sin 2 θ , while for a spherical boundary A = − π . The second term
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describes the frequency shift caused by neighboring molecules, which in the
Lorentzian sphere approximation can be represented as:

4π
∆f / f 0 = ⋅ χ .
3
The concept embodied in the Lorentzian sphere approximation has played an
important role in the evaluation of magnetic susceptibility effects on the MR
frequency shift ∆f . It is based on the assumption that for a homogeneous, isotropic
solution the microscopic local field acting on a spin can be evaluated as if this spin
were moving inside a hollow sphere embedded in the magnetized media, while the
media outside the Lorentz sphere can be modeled as a homogeneous and isotropic
continuum. With these assumptions, the frequency shift ∆f in the presence of
external static field B 0 is described by Eq. [3.3]. It should be noted, however, that in
biological tissues exhibiting anisotropic structure (i.e., white matter in the brain), the
Lorentzian sphere approximation is no longer valid and a more general approach
should be used (74).

3.2.3 Measurement of the Magnetic Susceptibility of BSA
A scheme employing orthogonal tubes was applied to measure the volume
magnetic susceptibility of the BSA solutions (62). Standard, 5mm diameter, 7’’ long,
glass "NMR tubes" were filled with degassed BSA solutions and sealed with
parafilm. A given tube was first oriented parallel to the magnetic field and then
perpendicular to the field. Under these conditions, the MR signal frequency
difference between the two orthogonal orientations will be determined only by the
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[3.3]

susceptibility effects created by the boundary of the tube (coefficient A in Eq. [3.2]).
Any other factors remain constant and, thus, are cancelled out.

During the experiment, since the tube is positioned in air instead of a vacuum, the
frequency difference between the two orientations will be (the same for both water
and Dioxane):

∆f = 2π ⋅ ( χ solution − χ air ) ⋅ γ ⋅ B0 ,

[3.4]

χ solution = χ water + ζ protein ⋅ ( χ protein − χ water ) + ζ Dioxane ⋅ ( χ Dioxane − χ water )

[3.5]

where

and ζ indicates the relevant solution-component volume fraction. Thus, by
measuring ∆f at different volume fractions of BSA ( ζ protein ), the volume magnetic
susceptibility difference between BSA and water ( χ protein − χ water ) can be

determined. Further, since χ water is a known parameter, the volume magnetic
susceptibility of BSA can be determined.

Susceptibility measurement experiments were performed on a Varian DirectDrive™
MR scanner based on a 4.7T horizontal-bore superconducting magnet with a
21cm-bore inner-diameter gradient and shim assembly using a 1.5cm diameter,
laboratory constructed, surface transmit/receive RF coil. A PRESS sequence was
employed for localized shimming and data acquisition from a 4×4×4mm3 voxel
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selected at the mid point of the cylinder's axial length. Forty minutes prior to
initiating experiments, a thermometer and all the tubes to be scanned were
positioned at one end of the magnet for temperature stabilization. As noted above,
each sample tube was first oriented parallel to the magnetic field B 0 and shimming
was performed on the selected voxel. The 1H resonance frequencies of water and
Dioxane were measured. Then, immediately following data acquisition, the tube
was carefully rotated about the voxel position so as to align it perpendicular to the
magnetic field and the signal frequencies were determined again. For both
orientations, the shim settings (currents in the shim coils) and the voxel positioning
were kept the same. At each orientation, thirty individual (not summed) free
induction decays were acquired with 4,000Hz bandwidth, 3s data sampling period,
and 10s TR.

Frequencies for both water and Dioxane

1

H resonances were determined

separately for each of the 30 individual spectra using Bayesian probability analysis
(84). During the 5min total acquisition time, the water frequency drifted about
0.022ppm while the Dioxane frequency fluctuated around a mean ± SD of 7.1187 ±
0.0002ppm, indicating that field drift was minimal. The water frequency drift was
presumably reflective of a ~ 2°K temperature decrease (~ -0.011ppm/°K) (85)). })
associated with relocating the sample to the observation coil. If any untoward
field/frequency shift was detected during the experiment, e.g., if a light rail train
passed by the scanner site (the scanner is ~ 150' feet distant from the train track),
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the experiment was repeated. The 1H resonance frequency of Dioxane (the mean
of all 30 individually analyzed data sets) was used to determine the frequency
differences between orthogonal orientations of the same sample contained in a
given tube.

3.2.4 Separation of magnetic susceptibility and exchange effects
To separate susceptibility and exchange effects, a scheme employing coaxial tubes
was employed. The inner tube (2mm outer diameter) was filled with aqueous
solutions containing different concentrations of BSA, including 0.5% Dioxane; the
outer tube (5mm outer diameter) was filled with water (no BSA) and 0.5% Dioxane.
Accordingly, the magnetic susceptibility of the BSA solution in the inner tube was
defined by Eq. [3.5], and the magnetic susceptibility of the reference solution (no
BSA) in the outer tube is:

χ ref =−
(1 ζ Dioxane ) ⋅ χ water + ζ Dioxane ⋅ χ Dioxane .

[3.6]

Since the orientation factor A in Eq. [3.2] nulls when both coaxial compartments are
parallel to the B 0 field, the

1

H MR signal frequency shift induced by the

susceptibility difference between inner and outer tubes is:

4π
4π
∆f / f 0 = ⋅ ( χ inner − χ outer ) = ⋅ ζ protein ⋅ ( χ protein − χ water )
3
3
Dioxane is not expected to undergo exchange or physically/chemically associate
with BSA molecules. Thus, the frequency difference of Dioxane resonances
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[3.7]

between inner and outer tubes is taken to reflect a pure susceptibility effect per Eq.
[3.7]. However the water frequency difference between inner and outer tubes
reflects both the protein induced susceptibility and exchange effects:

∆f water / f 0 =∆f e +

4π
⋅ ( χ inner − χ outer ) .
3

Note that ∆f e is also proportional to the volume fraction of BSA. Therefore, by
subtracting the frequency shift of Dioxane from the frequency shift of water, the net
frequency shift due to water-BSA exchange can be quantified.

The coaxial tubes MR experiment was conducted on a Varian Inova 500MHz
(11.74T) vertical bore high resolution spectrometer. The probe was equipped with a
variable temperature controller and all samples were stabilized at a fixed
temperature before and during the measurement. Data was acquired at two
temperatures: 286.5°K (same as with the 4.7T imaging scanner) and 310°K (similar
to body temperature). Samples did not contain D 2 O, commonly used for
field/frequency locking and shimming. A separate coaxial tube containing a
D 2 O/H 2 O mixture was used for shimming. After shimming, thirty individual free
induction decays were collected on each of the relevant coaxial samples, with
10,000Hz bandwidth, 2s acquisition time, and 10s TR. Radiation damping was
eliminated by detuning the receiver coil and employing a reduced filling factor (5mm
outer tube diameter in a RF coil greater than 10 mm in diameter).
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[3.8]

Because data were acquired without a field/frequency lock, and there was not
enough SNR for accurate evaluation of the Dioxane frequency in the inner tube
from a single acquisition, the following procedure was used to correct for field drift.
In each data set composed of 30 individual FIDs, the first FID acquired was used
as a reference; the frequency shift caused by field drift was calculated by
comparing the phase of the water signal in each of the 29 subsequent FIDs to the
reference FID. The time domain data from each individual acquisition were then
frequency shifted correspondingly and averaged (sum of 30 FIDs) after this
correction. The frequencies of each resonance (water and Dioxane) in the coaxial
tubes were determined from the summed FIDs for different protein concentrations
using Bayesian probability analysis (84).

3.3 Results
Examples of water and Dioxane spectra obtained in an orthogonal tubes
experiment and a coaxial tubes experiment are shown in Figure 3.1a and b. Double
peaks for water and Dioxane can be observed for the coaxial tubes experiment.
These peaks correspond to water and Dioxane in the outer (large amplitude
signals) and inner tube (small amplitude signals) compartments.
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a)

b)
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Figure 3.1 Examples of spectra (line broadening apodization filter of 1Hz) obtained
from the orthogonal tubes experiment. (a), and the coaxial tubes experiment after
averaging (b). The Dioxane resonances are shown vertically expanded (50x) in the
insets. Both experiments were carried out at the same temperature (286.5°K) and
the protein solutions in both experiments contained 7.5% (v/v) BSA and 0.5%
Dioxane. Resonance frequencies were determined by Bayesian probability analysis
(84). Estimated uncertainties of resonance frequencies in (a) are: 1.3E-5 ppm for
water and 2.5E-4ppm for Dioxane. Estimated uncertainties of resonance
frequencies in (b) are: outer-tube water 1E-5ppm, inner-tube water 3.9E-5ppm,
outer-tube Dioxane 9.7E-5ppm, inner-tube Dioxane 1E-3ppm.
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0.08

Figure 3.2 The dependence of magnetic susceptibility induced MR signal frequency
shifts on protein volume fractions. ∆f solution is the Dioxane MR signal frequency
difference between cylindrical NMR tube orientations parallel and perpendicular to
B 0 in the rotating tube experiment.

Figure 3.2 illustrates the observed frequency difference in the orthogonal tubes
experiment at different protein concentrations. Fitting Eq. [3.4] to the ∆f solution vs.
volume fraction of BSA data yields (mean ± SD): χ protein − χ water = (-0.107 ± 0.009)
ppm and χ water − χ air + ζ Dioxane ⋅ ( χ Dioxane − χ water ) = -(0.7513 ± 5E-4) ppm. Given the
susceptibility of water (-0.719ppm (86)), the estimated volume magnetic
susceptibility of BSA can be derived:

χ BSA =
( −0.826 ± 0.009)ppm .

Further, given χ Dioxane = -0.596 ppm (86), the magnetic susceptibility of air can be
derived, χ air = (0.0317 ± 5E-4) ppm. The positive magnetic susceptibility of air is
caused by the presence of O 2 , which is paramagnetic. This result is in excellent
agreement with the susceptibility of oxygen in air as estimated from first principles
using the Curie law, χ oxigen = 0.0316 ppm, given the known molar magnetic

O2 ) 3372 ppm ⋅ cm 3 ⋅ mol −1 at 13°C (86)) and its
susceptibility of pure O 2 ( χ m (=
volume fraction in air (21%). While this effect is small, it should be taken into
account for accurate measurements of magnetic susceptibility.
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[3.9]
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Figure 3.3 1H MR signal frequency difference of water (triangles) and Dioxane
(squares) between inner and outer coaxial tubes ( f inner − f outer ) / f 0 measured at
13.5°C (solid symbols) and 37°C (open symbols). Lines represent linear
regressions. The slopes of the fitted lines are: ( −0.45 ± 0.03) [ppm] for Dioxane,
and ( −0.28 ± 0.03) [ppm] for water at 13.5°C; ( −0.445 ± 0.03) [ppm] for Dioxane
and ( −0.216 ± 0.004) [ppm] for water at 37°C.

Figure 3.3 shows the 1H MR signal frequency difference between inner and outer
tubes for water and Dioxane in the coaxial tubes experiment at two temperatures.
Note that the 1H frequency shift of water is the sum of the magnetic susceptibility
effect and the water- exchange effect. Since Dioxane does not associate with BSA
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(vide infra), the frequency shift of Dioxane can be attributed solely to a susceptibility
effect:

∆f / f 0 |susceptibility =
∆f / f 0 |Dioxane =
−(0.45 ± 0.03) ⋅ ζ ppm .

[3.10]

As calibrated by Dioxane's pure susceptibility induced frequency shift, a BSA
induced susceptibility effect will decrease the water 1H resonance frequency. This
is in agreement with our previous orthogonal tubes measurement.

Having quantified the magnetic susceptibility effect, the contribution of water-BSA
exchange to the water MR signal frequency shift can be estimated by subtracting
susceptibility frequency shifts from the observed water frequency shifts:

at 13.5°C: ∆f / f 0 |exchange = ∆f / f 0 |water −∆f / f 0 |Susceptibility = (0.17 ± 0.03) ⋅ ζ ppm ,

[3.11]

at 37.0°C: ∆f / f 0 |exchange = ∆f / f 0 |water −∆f / f 0 |Susceptibility = (0.23 ± 0.03) ⋅ ζ ppm .

[3.12]

Hence, water exchange/association with BSA increases linearly with protein
concentration as would be expected. It results in a frequency shift in opposite
direction to that caused by protein susceptibility.
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3.4 Discussion
The present work examines the homogenous model system of a native protein in
solution. Two mechanisms through which proteins affect the water 1H MR signal
frequency

are

considered:

magnetic

susceptibility

and

water-protein

exchange/association. The magnetic susceptibility of a substance is related to the
electronic structure of its atoms. Protein density (g/ml) is greater than that of water.
The presence of proteins in aqueous solution increases the density of circulating
electrons (within molecular orbitals), thus making the solution more diamagnetic.
(Recall, diamagnetism is related to changes in the molecular electron currents
induced by the magnetic field.) According to Eq. [3.10] this decreases the water 1H
MR signal frequency. Water-protein exchange can be envisaged as a rapidly time
modulated interaction/association between water and multiple exchangeable sites
on protein residues (primarily –NH-, -NH 2 , -OH, -SH and –COOH). The overall
effect is a shift of the water 1H MR signal to higher frequencies. On a protein
volume fraction basis, the susceptibility effect is twice that of, and in opposition to,
the exchange effect. As shown in Figure 3.3, the susceptibility induced frequency
shift is not affected by temperature (as expected because small temperature
variations have little effect on molecular electronic structure), while the exchange
induced frequency shift is affected by temperature. This is also expected because
temperature

influences

conformational

the

dynamics,

rates

which

of

kinetic

consequently

phenomena between water and protein (87).
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processes
alters

including

protein

exchange/association

As noted above, in native BSA solution at 37°C the amplitude of the exchange
effect is one half and opposite in sign to that of the susceptibility effect. It is likely
the water-protein exchange effect is even smaller in biological tissues where
proteins are often cross-linked, associated with membranes or other proteins and
sites for water association are reduced in number. Indeed, as a globular protein,
BSA has a hydrophobic core and a hydrophilic surface, which makes it soluble in
water. Its structure is representative for a large group of proteins: hemoglobulins,
immunoglobulins, albumins, enzymes, etc. Considering brain in vivo, apart from the
soluble proteins, the other major protein class is insoluble in water (88-90), namely,
fibrous proteins (scleroproteins), which form neurofilaments and microtubules, etc.
These proteins are found as aggregates due to hydrophobic groups that stick out of
the molecules, providing mechanical strength and rigidity for the tissue as well as
for physiological functions. Due to their aggregated structural features, protons on
the surface of fibrous proteins are more likely to have very short 1H T 2 relaxation
time constants, further resulting in a reduction of water frequency shifts due to
exchange effects. Hence, comparing with the model native protein solution
employed herein, it is likely exchange effects in vivo will contribute even less to the
water MR signal frequency shift. At the same time, protein contribution in vivo to
tissue magnetic susceptibility will remain the same as measured herein. (The
reader is reminded that the contribution of highly anisotropically organized protein
structures to the water 1H MR signal frequency shift cannot be described in terms of
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the Lorentzian sphere approximation, Eq. [3.3], a more general approach must be
applied (74).)

This method employed herein for separating magnetic susceptibility and exchange
effects relies on having a reliable internal reference, Dioxane, that does not
interact/associate with BSA. Several lines of evidence support the choice of
Dioxane for this purpose. First, the Dioxane 1H MR signal in the compartment with
BSA showed no line broadening, consistent with a lack of significant
interaction/association between Dioxane and BSA. Second, measurements of
Dioxane frequency shift vs. protein concentration at 13.5°C and 37°C (see Figure
3.3) showed no temperature dependence, again consistent with a lack of significant
interaction/association between Dioxane and BSA (as was not the case for water,
Figure 3.3). Third, comparison of results obtained in the orthogonal tubes
experiment with those from the coaxial tubes experiment further confirms that
Dioxane exhibits no (or negligible) interaction/association with BSA. Indeed, we
have determined from the orthogonal tubes experiment that the magnetic

( −0.826 ± 0.009)ppm , see Eq. [3.9]. Substituting this
susceptibility of BSA is χ BSA =
value into Eq. [3.7] we can predict that the frequency shift of the Dioxane MR signal
between inner and outer compartments in the coaxial tubes experiment should be

( ∆f / f 0 ) Dioxane =
−(0.45 ± 0.04) ⋅ ζ ppm . This follows only if the frequency shift of the
Dioxane signal is solely due to the magnetic susceptibility effect. Direct
measurement as described in Eq. [3.10] is in an excellent agreement with this
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prediction. That is, the frequency shift of Dioxane between inner and outer tubes is
not affected by exchange/association with BSA, and reflects a pure susceptibility
effect.

Although some studies suggest that Dioxane and water could affect each other’s
frequencies by ‘bifunctional hydrogen bonds’ (91), the absolute frequencies of
Dioxane and water are not important in these measurement. Further, the same
Dioxane concentration is maintained in both inner and outer coaxial tubes, thus the
frequency difference between the two coaxial tubes is due solely to protein content.

These quantitative results regarding volume susceptibility are reported with respect
to the volume fraction of BSA, which was calculated based on directly weighing
protein powder and the measurement of solution volume. The estimated protein
density in our solution was 1.332 g/cc, which is lower than the density of fully “dry”
serum albumin reported as 1.381 g/cc (92). It is known, however, that crystalline
protein is likely to contain approximately 10% (w/w) of water (83). Hence, from the
density difference we can estimate that the water content in our purchased BSA is
10.6% (w/w) – similar to previously reported. Accordingly, we can recalculated the
volume susceptibility of “pure” BSA as χ ( pure BSA) = −0.841 ppm and the gram
susceptibility as
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χ g ( pure BSA) = −0.609 ppm[ml / g ] ,

[3.13]

which is in good agreement with previously reported “common χ g value” of
proteins: -(0.587 ± 0.005)*10-6ml/g (93). Using the corrected value, we can reexamine the contribution of “pure” proteins to the water MR signal frequency shift at
37°C:

∆f / f 0 susceptibility =
−0.51 ⋅ ζ pure ppm
0.26 ⋅ ζ pure ppm
∆f / f 0 exchange =

[3.14]

The possible role of water-protein exchange effects in the formation of 1H water MR
signal frequency shifts was first addressed by Zhong et al. (42). Data presented
herein are different from their results, which utilized TSP as an internal reference.
While TSP is broadly used in high resolution

1

H NMR experiments, our

experimental data (see Appendix) suggests that TSP exhibits significant interaction
with BSA. The line width of TSP in the coaxial tube with BSA is largely broadened
compared to the line width of TSP in the coaxial tube without BSA. The frequency
shift of TSP between the two coaxial tubes per unit volume BSA (-1.03 ± 0.07ppm)
does not match the susceptibility effect determined by our orthogonal tube
experiment (-0.45 ± 0.04 ppm), indicating the TSP frequency shift results from more
than just the susceptibility effect of BSA. It is well known that an important function
of serum albumin is to bind long-chain fatty acids and other like molecules, serving
as a major transporter for free fatty acids via the plasma (94,95). Although the TSP
is only equivalent to a 5-carbon chain, it is possible that BSA weakly binds with
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TSP, resulting in a certain degree of exchange driven frequency shift. Earlier
studies have reported that the chemical shift of TSP was dependent on the protein
concentration ((81)).

3.5 Conclusion
In this study, the effects of protein content on water 1H frequency shifts were
examined. These shifts will contribute to the phase shift in vivo at high field. Two
previously suggested mechanisms were determined separately and quantitatively
by an experiment employing coaxial tubes and native protein (BSA) solutions.
Results indicate that the protein susceptibility effect is twice that of, and in opposite
direction to, the exchange effect.

Excellent

agreement

between protein

susceptibility measurement employing coaxial tubes and measurement employing
an orthogonal tube protocol confirmed that Dioxane is a reliable marker for
separation of magnetic susceptibility and exchange effects. This is further
supported

by

a frequency

shift,

temperature

dependence

study.

These

experimental findings with native protein solution provide insights into the influence
of protein content on water 1H MR signal frequency. For structurally cross-linked
proteins in vivo, the susceptibility effect is expected to play an even more
substantial role in affecting the water 1H MR frequency.
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3.6 Line-broadening interaction between TSP and BSA
TSP (2,2,3,3-tetradeuterio-3-trimethylsilyl-propionate, 0.5% (w/w), 29mM) powder
was added to the BSA stock solution and a control solution without BSA. The same
experiment employing coaxial tubes as described in the main text was conducted to
compare the TSP 1H MR signal frequency change with that of Dioxane. However,
the BSA solution was placed in the outer tube for improved detection (TSP has a
broad line width in the presence of BSA).

Figure 3.4 Spectrum (line-broadening apodization filter = 1Hz) from experiment
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employing coaxial tubes. Concentric tubes were positioned parallel to the B 0 field,
with temperature stabilized at 37°C. The solution in the outer tube contained 7.5%
(v/v) BSA, 0.5% Dioxane, and 0.5% (w/w) TSP; the solution in the inner tube
contained 0.5% Dioxane and 0.5% (w/w) TSP. Dioxane and TSP resonances are
vertically expanded (50x) in the insets.

Figure 3.4 demonstrates a significantly broadened TSP resonance in the presence
of BSA. Line broadening is not observed for the Dioxane resonance. With regard to
the frequency shifts at this particular protein concentration: TSP is shifted by 0.072ppm whereas Dioxane is shifted by -0.031ppm. If TSP is taken as an internal
reference and the BSA exchange effect on signal frequency is calculated, it would
be +0.055ppm instead of +0.015ppm (using Dioxane as reference), a substantial
systematic error.

[
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Chapter 4 Gradient Echo Plural Contrast Imaging
(GEPCI) – Basic and Derived Contrasts 3

4.1 Signal Model and Data Processing of GEPCI

4.1.1 Multi-channel data processing
Multi-channel data were combined using a generalization of previously developed
algorithm (82) that allows for the optimal estimation of quantitative parameters,
such as MR signal decay rate constants. In original implementation it was assumed
that the data from different channels are already phased coherently. Applying this
algorithm for multi-gradient echo signal obtained from an M-channel RF coil, we get
the following result:

Scomb (TEn ) =

1
M

M

∑λ
m =1

m

Sm (TE1 ) Sm (TEn )

[4.1]

where index n enumerates gradient echoes, index m enumerates RF channels,

Scomb (TEn ) is a combined signal corresponding to the gradient echo time TE n ,
Sm (TEn ) are signals from individual channels, and parameter λm is

λm =

3

1
M

M

∑σ

m ' =1
2
m

2
m'

σ

Most contents in this chapter have been published in Luo J, Jagadeesan BD, Cross AH, Yablonskiy DA. Gradient

Echo Plural Contrast Imaging – Signal model and derived contrasts. NeuroImage 2012; 60:1073-1082
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[4.2]

Here σ m are noise amplitudes (r.m.s.) in corresponding channels (m). They are
calculated by averaging data from 10x10 pixel area in the corner of magnitude
images Sm (TEn ) . Since noise levels of each acquisition (echo times) are similar,
they are subsequently averaged to obtain σ m for a single channel. The Rician
nature of noise in magnitude images does not affect estimate of parameters λm
since they are ratios of σ m2 . The parameters λm provide additional signal weighting
and reduce contribution of RF channels with high noise level.

Generalizing this consideration for complex data leads to the following algorithm for
data combination:

Scomb (TEn ) =

1
M

M

∑λ
m =1

m

Sm (TE1 ) Sm (TEn )

[4.3]

where Sm (TE1 ) is a complex conjugate of the signal from channel m at the first
gradient echo time TE 1 . Since signal phases of different channels differ by their
initial values ϕ 0m but have the same frequency f, as described in

ϕ m (TEn ) =ϕ 0 m + 2π f ⋅ TEn
this procedure removes destructive interference of data due to the term ϕ 0m from
multiple channels. The procedure described by Eq. [4.3] is applied to each voxel in
the image.
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[4.4]

4.1.2 Phase Unwrapping and Multi-channel data
In order to generate GEPCI images, data from multi-channel RF coil should first be
combined in a single data set. Figure 4.1 demonstrates the phase unwrapping and
channel combination procedure proposed in this manuscript (see detail description
in the Methods section). From phase maps shown in the top two rows of Figure 4.1,
we can see that combining phase images from different channels requires solving
two problems. First, individual receivers have different phase offsets, as described
in Eq.[4.4]. To address this issue,for each voxel we multiplied signal from each
channel by the complex conjugate of data from the first echo of the corresponding
channel, thus eliminating the phase offsets of each receiver coil. Data from all
channels were then averaged with their sensitivity weighting per Eq.[4.3] to achieve
optimal SNR with minimum error in parameters estimate (82). Second problem is
that phase images are affected by ‘wraps’, where jumps of 2π happen between
adjacent voxels due to phase values of 2πm + θ (m is integer) are encoded as
identical. This problem becomes more pronounced at longer echo times. Usually
phase unwrapping is accomplished in the image domain, where different algorithms
have been used (see for example (96,97)). Here we take advantage of having
gradient echoes corresponding to multiple TE and unwrap signal phase in the time
domain for each imaging voxel. Frequency maps were then generated by fitting
phase data for each voxel as function of the gradient echo times per Eq. [4.4]. Note
that difference in wrapping pattern in the phase image corresponding to different
TE does not affect this fitting procedure and resultant frequency maps. Though for
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areas of the brain with strong field inhomogeneities additional unwrapping of the
frequency map in the image domain might be required, this was not the case in any
of our data.

Figure 4.1 Example of the phase images before and after channel combination
procedure. Top two rows show phase images at TE equals 4 ms, 12 ms, 20 ms, 28
ms from 2 different channels; Third row shows combined phase images obtained
after channel combination according to Eq. [4.3]. First image in this row is zero
because the phase of the first echo is compensated during channel combination.
Bottom row shows phase images after unwrapping in the time domain as discussed
in the methods section.
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4.2 Experiment Protocol of Gradient Echo Plural Contrast Imaging
Brain images were collected from 5 healthy volunteers and one subject with
Relapsing-Remitting MS who underwent brain MRI studies on a Siemens 3T Trio
MRI scanner (Siemens, Erlangen, Germany). A 12-Channel phased-array head coil
was used to obtain a 3D version of the multi gradient echo sequence with a
resolution of 1x1x2 mm3 or 1x1x3 mm3, FOV of 256 mm x 192 mm and 11 gradient
echoes (TR = 50 ms; minTE = 4 ms; delta-TE = 4 ms; bandwidth = 510Hz/Pixel; FA
= 30°). Further effective resolution enhancement was achieved with zero-filling in kspace. Standard SWI images were also acquired with the same resolution and
TR=27 ms, TE=20 ms, bandwidth 120Hz/Pixel, FA=15° for healthy volunteers; and
standard FLAIR images were acquired for the MS patient with resolution 1.3x0.9x3
mm3 by turbo spin echo sequence: TR=10 s, TI=2600 ms, TE=82 ms, turbo factor =
13, Echo trans per slice = 15. All studies were conducted with the approval of
institution IRB.

4.2.1 Protocol Optimization
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Figure 4.2 Comparison between signals result from TR = 40 ms (black) and TR =
50 ms (blue). Circles represent gray matter; triangles represent white matter.

Since in GRE it takes very long TR to get proton density weighting, in GEPCI, S 0 is
targeted to be T1 weighted. We are trying to find an optimal combination of TR and
flip angle for contrast between gray matter and white matter within reasonable time,
and with sufficient SNR. From Figure 4.2, it is obvious that TR 50 ms gives both
better signal and contrast than TR 40 ms. From Figure 4.3, we can get some
phenomenological information on the GM/WM contrast. Black lines represent signal
intensity of GM (from a single channel, before combining) and blue lines represent
signal intensity of WM. A series of signals from 6 echoes are displayed. As we can
see, the contrast between gray matter and white matter switches at around α = 18o,
which is also when signal reaches maximum. As α increases, contrast between GM
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and WM increases yet signal intensity decreases. Flip angle of 30o was finally
selected for the best contrast-to-noise ratio (CNR), with TR of 50 milliseconds.
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Figure 4.3 Signals in different echoes TR = 50 ms. Blue lines represent white
matter; black dotted lines represent gray matter.

4.3 Basic Contrasts of GEPCI

4.3.1 Generating basic GEPCI images
Combined data are analyzed assuming mono-exponential signal decay and taking
into account Eqs. [4.3] and [4.4]:

Scomb (TEn ) =
S02 ⋅ e − R2 *( TEn +TE1 ) ⋅ ei 2π f ( TEn −TE1 )
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[4.5]

Before fitting Eq. [4.5] to complex data (magnitude and phase images), the phase
data were unwrapped for each voxel in a time domain using 11 data points (TE n ). If
the frequency for some areas is high enough to cause multiple phase wraps within
delta TE (that is 250Hz for our delta TE of 4 ms), then after time domain
unwrapping there will be isolated areas in the frequency map that should be further
unwrapped in spatial domain. Though most parts of the brain frequency map gets
unwrapped already after the time domain procedure. The fitting procedure
produces three naturally co-registered basic GEPCI images: a quantitative
R2*=1/T2* map, a T1-weigted (S 0 ) image and a frequency (f) map. The frequency
maps are then subsequently high-pass filtered to remove effects of macroscopic
field inhomogeneities. Herein we use a 7x7 (out of 256x256) averaging matrix. Note
that this filter is a rough approximation. Application of recently proposed advanced
phase processing methods, e.g. SHARP method (98) or the projection onto dipole
fields (99), could result in a more accurate removing of the artifacts related to
macroscopic field inhomogeneities.

4.3.2 Basic GEPCI images
Example of basic GEPCI images is shown in Figure 4.4. The frequency map
presents significantly different contrast from the corresponding magnitude image
(T1w) or the R2* map. White matter (WM) showed up darker than the cortex and
caudate, putamen in the deep grey matter area on frequency map; this contrast is
reversed on T1w image; on the R2* map however, WM showed up darker than the
87

caudate and putamen, although still brighter than the cortex region. The nature of
WM “darkness” on phase images was explained in (61) based on the introduced
there Generalized Lorentzian approach. According to this theory, the longitudinal
structures (myelin sheaths, axons, neurofilaments, etc.) that comprise WM do not
contribute to the total frequency shift for the cylindrical axonal tracts even though
WM has higher magnetic susceptibility than the GM. The frequency map allows
superior delineation of the caudate, internal capsule, pallidum and putamen,
whereas the differentiation is not as clear on T1 weighted image or R2* map. Grey
matter/White matter boundaries are also clearly depicted on frequency maps.
These results are similar to previously reported with high field MRI (3).
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Figure 4.4 Example the basic contrast images generated by GEPCI technique from
two axial brain slices (first and second rows). Lower row shows detail picture of the
part of the images identified by a square. As described in Eq.[4.5], S0 is the T1w
image, R2* map is derived from the magnitude of the signal decay, and the third
image is a frequency map (f). The scale bar shows distribution of frequencies.
Structures pointed out on the frequency map are: 1) Optic Radiations, 2) Splenium
of Corpus Callosum, 3) Caudate, 4) Internal Capsule, 5) Putamen, 6) Pallidum, 7)
Internal Capsule.
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4.4 Derived Contrasts of GEPCI

4.4.1 Generating secondary derived GEPCI images
Several derived images can also be generated based on these basic GEPCI
images. First, a positive Frequency contrast Mask (FM) is created by setting
negative frequency values to unity, and normalizing positive frequency values to be
ranged from 0 to 1, such that 1 corresponds to zero frequency and 0 corresponds
to highest frequency. This procedure is similar to creating phase masks in standard
SWI procedure (100).

4.4.1.1 SWI-like images are generated using the following equation

S SWI −like (TE ) =⋅
S0 e

− R 2*⋅ TE

⋅ FM

4

[4.6]

Here the T1 weighted image S 0 is T2* weighted with a certain TE (we used
TE=20ms, which is typical echo time used for the SWI sequence on 3T systems)
and is multiplied 4 times by the frequency mask (FM), which generates an image
that mimics the standard SWI contrast (100).

4.4.1.2 GEPCI-SWI images are generated as follows

SGEPCI − SWI=
(TE ) e

− R 2*⋅ TE

⋅ FM

4

GEPCI-SWI images are free from T1 contrast contamination characteristic to the
standard SWI because they are generated using pure T2* weighting and phase
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[4.7]

contrast without S 0 term. Here we also use TE=20ms and multiply the magnitude
image 4 times with a frequency mask just as in original SWI (100).

Minimum intensity projection (minIP) images using seven slices were also
calculated for both the SWI-like and the GEPCI-SWI images.

4.4.1.3 GEPCI-T1f images

GEPCI-T1f images are derived by using only T1-weighted image (S0) and
frequency contrast mask:

SGEPCI −T 1F= S0 ⋅ FM 4
In these images GM/WM contrast is enhanced.

4.4.1.4 Fluid Suppressed T2* images (FST2*)
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[4.8]

Figure 4.5 An example of the histogram of GEPCI T1w image. Different brain tissue
components are indicated on the histogram：white matter (WM), grey matter (46),
cerebrospinal fluid (CSF). X0 is the position of the WM peak. The vertical line
indicates selected threshold that is used for CSF suppression in the FST2* images.

The goal here is to produce FST2* images that are T2* images with suppressed
CSF signal that would “look similar” to FLAIR (fluid attenuated inversion recovery)
T2 weighted images. Standard FLAIR-T2 images are obtained by using a long
inversion pulse that suppresses the signal from CSF (long T1 component), and a
long TE that produces heavy T2 weighting (101). To produce FST2* images we
create a CSF mask (M CSF ) using the T1-weighted image (S0). The S0 image is first
processed by FMRIB’s Automated Segmentation Tool (FAST) (102-104) to remove
the bias in image intensity caused by RF field inhomogeneities. Example of the
distribution of the corrected S0 values (T1w image) is plotted in a histogram, Figure
4.5; the signal intensities are ranked as S(WM)>S(46)>S(CSF), thus highest peak
on the right corresponds to WM. Gaussian fitting was done on the right half of the
main peak in this histogram determining peak position, X0, and standard deviation,
STD. This allows thresholding of CSF signal. In this paper voxels that have S 0
values that are bigger than (X0 – 1.96 * STD) were considered as non-CSF area
and their values were set as unity in M CSF mask. Voxels with intensity below (X0 –
1.96 * STD) were normalized from 0 to 1, so that the darkest-appearing voxels on
T1w image is 0, and brightest-apprearing voxels (those that are close to gray
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matter) is 1. The FST2* images are produced by multiplying the T2* map with the
CSF mask n times.

n

S FST
=
T 2 * ⋅ M CSF
2*

Since the voxels that are set to 1 in the mask will not get much attenuation in the
resulting image, the threshold should be selected within the grey matter area to
achieve a better suppression of CSF signal. In this manuscript we have compared
several choices of parameter n (1~4). The optimal choice of threshold and ‘n’ is
subject to further discussion. These images look like FLAIR images in the way that
they have essentially T2* contrast (similar to T2 weighting) with strongly attenuated
CSF signal.

4.4.1.5 T2*-SWI Images

In some applications like multiple sclerosis (MS) it might be advantageous to
generate images that simultaneously show venous structure and T2 hyperintense
lesions (105). Using GEPCI, this can be achieved by combining GEPCI-SWI and
GEPCI FST2* images. Indeed, GEPCI-SWI data shows veins as dark contrast but
are insensitive to hyperintense lesions. On the other hand, T2 hyperintense lesions
are also hyperintense on FST2* images. We found that good visualization of the
combined distribution of T2 hyperintense lesions and veins (and possible iron
deposition) is achieved by multiplication of FST2* and GEPCI-SWI images so that
T2 hyperintense lesions are contrasted by hypointense veins running through:
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[4.9]

S FST 2*=
S FST 2* ⋅ SGEPCI − SWI
− SWI

[4.10]

It can also be applied to assess vascularity of tumors where tumors are bright on
FST2*, and vascular structures inside tumors are dark.

4.4.2 Results of Derived Images
4.4.2.1 GEPCI-SWI and SWI-like Images

In this study, by combining basic GEPCI data sets in a manner analogous to
standard SWI approach, we generated SWI like images and compared them to the
Siemens scanner generated SWI data (Figure 4.6A and 4.6B). The images
resulting from the standard SWI sequence were as usually contaminated by T1weighting. This remains the case when GRE with several gradient echoes is used,
although multi gradient echo approach allows increasing the signal to noise ratio
(SNR) and contrast to noise ratio (CNR) of brain SWI images (106). The most
obvious consequence of this T1 contamination is the ‘dark CSF’ area, particularly in
the mIP images, which reduces contrast between the veins and CSF (Figure 4.6A
and 4.6B). One way to resolve this issue was suggested by Haacke et al (107), that
is to use small flip angles to minimize darkening of CSF area. Imaging parameter
on 3.0T MRI scanner was proposed: FA 12-17 degrees, TR 25-35 ms, TE 20 ms,
BW 80-100 Hz/pixel. As our images showed, although imaging parameters we
used for the standard SWI imaging is within the recommended range, additional
adjustments shall be made to get desirable SWI contrast. Further, using small flip
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angle to minimize darkening of CSF area will inevitably result in loss of grey white
contrast on the SWI images.

Using GEPCI approach allows overcoming this problem without losing signal.
Indeed, GEPCI data were acquired with imaging parameters that maximize the T1weighted contrast for S(108) as well as preserving SNR characteristic for optimal
flip angle. In contrast to the SWI–like images and the standard scanner generated
SWI images, GEPCI-SWI images had preserved bright CSF signal as well as
preserved GM/WM contrast. This phenomenon maybe particularly useful in
characterizing the deep veins in the area of the lateral ventricles. Such information
about the deep veins is likely to be useful in surgical planning for patients who are
set to undergo procedures such as placement of deep brain stimulators (109). Note
that, the GEPCI-SWI image is as sharp as or even sharper than conventional SWI
images with regard to vessel delineation. Also note that the GEPCI-SWI
significantly enhances the gray and white matter interfaces, as seen in Figure 4.6A
and 4.6B.
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Figure 4.6A.
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Figure 4.6B.

Figure 4.6A and 4.6B. Two examples of standard SWI images (left column - a,b),
GEPCI-SWI images (middle column - c,d) and GEPCI-derived SWI like images
(right column – e,f). The bottom row is the minIP corresponding to the images in the
upper row. Standard SWI images (a & b) are obtained from Siemens automatic
reconstruction. The rest of the images (c-f) are all derived from the same GEPCI 3D
data set.

4.4.2.2 GEPCI-T1f Images

Another novel combination of the GEPCI basic images incorporates the frequency
map and the T1-weighting (S0). The grey matter area on T1-weighted images is
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darker than white matter. Considering the fact that grey matter tends to present
more positive frequencies in frequency maps than white matter, plus the transition
between gray and white matter on frequency map is more sharply delineated, we
explored enhancement of GM/WM contrast by multiplication of the GEPCI T1w
image with the frequency mask. The Resulting images (Figure 4.7) did indeed
demonstrate more crisp GM/WM borders as well as enhanced GM/WM contrast
compared to the T1w images. Deep grey matter structures such as caudate and
putamen nuclei are also clearly outlined on the GEPCI-T1f images. These images
are likely to be very useful in detecting malformations of cortical development in
patients with intractable epilepsy, since they are more likely to be sensitive to
blurring of the GM/WM interface from subtle cortical migrational abnormalities
(110). Multiple sclerosis lesions in cortex, typically not clearly resolved by standard
MRI (111), might be more clearly seen. Additionally, these images also offer a
promising new method to achieve GM/WM segmentation which will result in more
accurate volumetric data as well as improve data from cerebral perfusion studies.
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Figure 4.7 Examples of the GEPCI-T1f images obtained according to Eq. [4.8] (top
row), comparing with basic GEPCI-T1 weighted images (bottom row). GEPCI-T1f
images show excellent GM/WM matter contrast. Deep grey matter structure such
as caudate and putamen nuclei are also clearly outlined on the GEPCI-T1f images.

4.4.2.3 FST2* Images

Example of GEPCI FST2* image is shown in Figure 4.8. These images are similar
to FLAIR images in the way that CSF is suppressed based on tissue T1 properties.
However, unlike T2 weighted FLAIR images which are based on T2 weighting,
FST2* image is based on T2* map. Since difference between T2 and T2* values is
usually small, especially in well shimmed white matter areas (112) FST2* images
could be used to detect T2 sensitive changes in the brain, such as visualizing
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edema, hyperintense lesions (in multiple sclerosis (40)), cerebral infarctions, which
are usually well detected on the FLAIR sequences. Various degree of fluid
suppression has been shown in Figure 4.8, as we go from n=1 to n=4. Choice may
be made for different applications. For example, in MS brain part of the MS lesions
can be suppressed together with CSF signal when bigger ‘n’ is applied. We could
choose n=1 in order to maintain hyper-intensity of the lesions. Or since MS lesions
are likely to appear in white matter areas, we could avoid suppression of lesions by
designing WM masks based on GEPCI-T1w images. Additionally, based on its
quantitative T2* nature, it could also be used to detect T2* sensitive changes, such
as microbleeds or microcalcifications in the brain. Indeed, the fluid suppression
based on the GEPCI-T1w image will not suppress artery signals on the T2* map,
yet it should not affect most brain area.

Figure 4.8 Example of the FST2* images (obtained using Eq. [4.9] with different
parameter n), and corresponding FLAIR T2 images. Top row – images from a
subject with relapsing remitting MS, bottom row - images from a healthy subject.
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Different degree of suppression is shown from first column through fifth column, as
parameter n grows from 0 to 4 in Eq. [4.9]. The case with n=4 for the MS patient
shows image resulted from applying suppression of n=4 with exclusion of white
matter area.

4.4.3 Possible applications of GEPCI in Clinical Arena
4.4.3.1 GEPCI in MS

GEPCI technique could also be applied to monitoring patients with multiple
sclerosis. Typical MRI protocol for detecting MS includes FLAIR (fluid-attenuated
inversion recovery), T2-weighted spin-echo, and T1-weighted spin-echo (including
with and without Gd-enhancement) (113,114). Phase imaging and susceptibility
weighted imaging has also been proposed for identification of MS lesions (47,115).
While typical MRI protocol aims at imaging the contrast due to variations in the
tissue characteristic relaxation rates, which are likely to represent lesions that are
the result of myelin and/or axonal loss, or inflammation, the SWI and phase
imaging are able to visualize small veins within white matter, which might help
resolve the timing of interactions between venous structures and MS lesions. With
the whole set of GEPCI images, as shown in Figure 4.9, we can obtain information
on both the MS lesions and white matter veins within a single acquisition.
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Figure 4.9 Examples of a series of GEPCI images applied to disease of Multiple
Sclerosis. a) GEPCI-T1weighted image; b) frequency map; c) GEPCI-T1f image; d)
GEPCI-SWI image; e) T2*-SWI, result from d multiplied by FST2* image; f) FLAIR
image. Most MS lesions (hyperintence on e and f) are seen around veins; green
arrow indicates example of lesion that is not affiliated with identifiable blood
vessels.

MS lesions are identified as hypointense on GEPCI-T1w image (Figure 4.9a), and
hyperintense on FST2* (Figure 4.8) due to increased T1 and T2* relaxation times.
The T2* values in the lesion area could be further used for more quantitative
assessment of MS lesions (40). GEPCI-SWI image (Figure 4.9d) shows veins
without apparent indication of lesions. Lesions that are slightly hyperintense on
frequency maps are darkened on T1f (Figure 4.9c) compared to T1weighted image
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(Figure 4.9a). Veins also appeared on T1f image because of frequency map. Thus
visualization of the distribution of lesions and their relation to veins (and possible
iron deposition) is achieved by multiplication of FST2* and GEPCI-SWI images
(Figure 4.8 with n=4 and Figure 4.9d), so that hyperintense lesions are contrasted
by dark veins running through. This idea is similar to that recently proposed in (105)
who combined FLAIR images acquired at 3.0 T and SWI acquired at 7.0 T.
However, with GEPCI images, we easily achieve similar contrast from a single
acquisition and complete, intrinsic co-registration. Comparing Figure 4.9e and
Figure 4.9f, lesions that are hyperintense on standard FLAIR images are also
clearly seen on the fusion of FST2* and SWI image where veins associated with
MS lesions are readily observed. However, not all lesions in Figure 4.9 are
associated with veins (e.g. green arrow on Figure 4.9e and 4.9f), and the
underlying relationship between veins and pathology of MS remains to be
investigated.

4.4.3.2 Other Possible Applications

The advantage of having a battery of images with multiple contrasts can have
advantages for numerous clinical applications. For example, combining GEPCISWI and GEPCI-T1f images, can potentially be used to correct for venous
contamination in dynamic susceptibility contrast MR perfusion maps such as
obtained in stroke patients (116). In some patients, cavernous malformations can
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be associated with epilepsy. With co-localized both SWI and T1f contrasts (venous
and GM/WM delineation), it is possible to visualize the cavernous malformation and
also evaluate its relationship to the adjacent cerebral cortex. This may provide new
insights into the mechanism of epileptogensis in these patients and allow for better
surgical planning (117,118). This combined contrast could also be useful in colocalizing subtle cortical malformations which may be found in the vicinity of
complex venous abnormalities in some patients with epilepsy. The preservation of
cortical GM/WM detail and representation of venous anatomy is also likely to be
useful in surgical planning in patients with brain tumors who are set to undergo
biopsies or curative resections (119,120). Based on these images, the surgeon will
be better able to avoid prominent veins at the tumor margins as well as estimate
the relationship of the tumor resection margins to eloquent areas of the cerebral
cortex at the same time.

4.4.3.3 Potential Improvements

Although a number of novel contrast mechanisms have been highlighted in this
manuscript, several limitations of the present study must also be mentioned. Most
importantly, in this manuscript we have not discussed issues related to magnetic
field inhomogeneities and their influence on quantitative results obtained with
GEPCI technique, especially on quantitative evaluation of T2* relaxation time
constant. Influences of field inhomogeneities are particularly significant around the
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tissue/bone or tissue/air interfaces such as sinuses, ear canals, etc. However,
away from these areas and for high resolution imaging as was used herein, this
issue creates only minor problems in most parts of the brain. Detailed discussions
of these issues can be found elsewhere (see for example (72,121,122)) and will
also be addressed in our future publications. On the other hand, the non-local
nature of frequency shift should also be noted when interpreting the derived
contrasts based on application of the frequency masks. For example, the edge of
the brain has some artifacts due to improper removal of the background field.
Another example would be where there are sharp transitions in susceptibility of the
brain tissue, e.g. the deep nuclei or ventricles. One might notice that the structures
in frequency map are not always the same as that in magnitude images. In such
cases tissue magnetic susceptibility will affect frequency map not only at the
location of susceptibility variations but also in the surrounding areas. One of the
ways to deal with this problem is already mentioned in the introduction quantitative
susceptibility mapping (59,98,123-127).

Another potential area of improvement includes accounting for the multicompartment tissue structure. Quantification of myelin-bound and free water
fractions by a multiexponential analysis of the T2 decay has been discussed
(128,129). Signal obtained based on a Carr-Purcell-Meiboom-Gill (CPMG) or Turbo
Spin-Echo (TSE) sequence with multiple TEs was modeled by three pool model
(130), or four pool model (131), or by non-negative least squares (132). Recently, it
has been shown that T2* decay, which is measured by multi-echo gradient echo
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sequence, could also be used for extraction of myelin water fraction (133,134).
However these issues are beyond the scope of the current manuscript.

4.5 Summary
The GEPCI technique based on post processing of the multi-echo GRE data
produces high quality frequency maps, high resolution R2* maps and T1-weighted
images. These data sets can then be combined in novel ways to produce high
resolution images which can offer excellent depiction of the intracranial venous
system (SWI like and GEPCI-SWI images), images which promise to significantly
improve the delineation of cerebral grey and white matter interfaces (GEPCI-T1f
images) and GEPCI-FST2* images that look similar to FLAIR images. These novel
imaging data sets can potentially find clinical applications in studying a variety of
common neurological disorders. They can also find applications in basic neuroanatomical and neuropathological research. Most importantly, these images with
novel contrast properties can be obtained without any increase in acquisition time,
and they are naturally co-registered obviating additional costs in terms of scanner
time and personnel.
[
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Chapter 5 Mapping T2* - Application of GEPCI to
Monitoring Multiple Sclerosis

5.1 GEPCI images compared to Clinical Standard Spin Echo images
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Figure 5.1 compares the images acquired by clinical standard sequences and
GEPCI images of a patient with Relapsing-Remitting MS. Red arrows point to MS
lesions; Blue arrows point to veins.
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Figure 5.2 compares the images obtained by clinical standard sequences and
GEPCI images of a patient with Secondary Progressive MS.

Clinical images: T1w (T1-weighted), T2w (T2-weighted), FLAIR (Fluid Attenuated
Inversion Recovery). GEPCI images, as introduced in Chapter 4, are: T1w -S0
(GEPCI T1 weighted), T2* (GEPCI T2* map), FST2* (Fluid Suppressed T2* map),
T1f (GEPCI T1 frequency image), SWI (GEPCI Susceptibility Weighted Image),
T2*-SWI (GEPCI T2* map - SWI).

Tissue delineation is similar between the first panel (clinical images) and the
second panel (GEPCI images) in Figure 5.1 and Figure 5.2. MS lesion contrast is
well resolved with GEPCI (hypointense on T1w image and hyperintense on T2*
map), thus allowing standard identification of MS lesions. All lesions that are seen
on SE sequences (T1w, T2w, FLAIR) are also revealed by GEPCI.

Images shown above (Figure 5.1 and Figure 5.2) demonstrated several advantages
of GEPCI over standard SE sequences for evaluation of MS. First, images obtained
with GEPCI appear highly similar to standard scans; hence, they can be used in a
reliable and conventional way for a clinical evaluation of the disease. Second,
GEPCI-T1w images, GEPCI-T2* maps and FST2star maps are generated from a
single dataset; that is, they are inherently coregistered. Third, the GEPCI technique
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is based on gradient echo MRI and uses small flip angles as compared to spinecho based techniques; hence it can be safely used in high-field MRI. Fourth, the
acquisition time for simultaneous generation of these three images is considerably
reduced compared with their equivalent SE sequences (6 min 40 sec) for GEPCI
against a total of 15 min scan time for three scans in a standard clinical protocol.
Fifth, GEPCI offers additional contrasts compared to SE sequences that might
provide more insights to disease evaluation.

More importantly, the major advantage of GEPCI approach is its quantitative nature
(T2* relaxometry) which can be used to quantitatively evaluate the severity of tissue
damage in MS brain, based on the scoring method introduced in next section 5.2.

5.2 Quantification of Tissue Loss 4

5.2.1 Tissue Damage Score (40)
To utilize the quantitative nature of GEPCI-T2* map, we introduce quantitative
parameters to score the severity of the disease based on T2* (or R2*) changes in
MS lesions.

4

Most contents in this section have been published in Sati P, Cross AH, Luo J, Hildebolt CF, Yablonskiy DA. In

vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging
technique. NeuroImage 2010; 51:1089-1097.
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Each MS lesion voxel in GEPCI technique is characterized by an associated
quantitative T2* relaxation time constant. We hypothesize that the R2* relaxation
rate constant (R2*=1/T2*) will provide information on lesion severity. This
hypothesis is a natural step because MS tissue damage involves loss of myelin
lipids accompanied to a variable degree by loss of intracellular proteins, including
axon proteins. In this process, R2* relaxation rate constant will progressively
decrease from normal tissue values to values typical for interstitial fluid or CSF that
is practically devoid of macromolecules. This supposition is in agreement with
correlation established between tissue T1 and T2 values and tissue damage in MS
reported in Schmierer et al. (2008) and Seewann et al. (2009). Recall, that
R2*=R2+R2′, where R2=1/T2 and R2′ reflects contribution from mesoscopic field
inhomogeneities generated mostly by the presence of blood vessel network in the
brain tissue (122). Recent work has evaluated the tissue-specific R2′ relaxation rate
in the healthy human brain (He and Yablonskiy, 2007). Using this data, we found
R2′ value for white matter at 1.5 T to be equal to 0.35 s−1, and at 3 T it is 0.7 s−1,
both are much smaller compared with the typical white matter R2 value that is
approximately equal to 15–16 s−1 (Neema et al., 2009). The GEPCI technique,
therefore, provides a quantitative measure of a tissue specific relaxation time T2*
(equal to 1/R2*) that is very close to T2 measured using spin-echo sequences.
Based on this consideration, we adopted the following procedure for estimation and
scoring of tissue damage in MS.
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First: design masks that contain only white matter, including both normal-appearing
and lesioned areas. These masks are drawn manually on GEPCI-T1w images
using home-built Matlab programs. All gray matter structures (cortical and deep)
are excluded. Masks are applied on both GEPCI-T1w images and GEPCI-T2*
maps. Then R2* histograms of the voxels inside masks of all slices are generated
using a bin width of 0.3 s−1 ranging from 0 s−1 up to 30 s−1. For control subjects
these histograms look almost like ideal Gaussian distributions. For subjects with
MS these histograms have a large peak with a quasi-Gaussian shape
[corresponding to normal-appearing white matter (NAWM)] and a strongly elevated
non-Gaussian tail on the left resulting from the presence of the MS lesions (see
example in Figure 5.3). Second: define the level of tissue damage, or tissue
damage score (TDS), for each voxel in MS lesions based on the tissue R2* value.
The characteristics of the WM peak are determined using a standard Gaussian
function that is fitted to the R2* distribution. To remove any influence on the fit from
the tail existing in the R2* distribution of MS patients, we fit only the upper half of
the R2* histogram. We define the “normal reference” R2* value as corresponding to
the center of the NAWM peak (R2*c) obtained from the fitting procedure. As we
already mentioned, in MS, tissue damage occurs through the loss of
macromolecules, mainly myelin and proteins in axons, leading to reduction in tissue
R2*. Hence, for each voxel in MS lesion with a given R2* value, the tissue damage
score (TDS) is determined as:
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TDS =

R 2*c − R 2*
R 2*c

[5.1]

In addition to defining TDS for each voxel, we can also define the tissue damage
load (TDL) for a given patient. This is done by summing TDS over all the voxels in
MS lesions:

TDL= V ⋅ ∑ TDS

[5.2]

N

where N represents the total number of voxels in the MS lesions in cerebral white
matter. We have also multiplied the sum by the voxel volume V (mm3) to make this
definition independent of the voxel resolution of the MRI pulse sequence. The
tissue damage load, thus, assesses both the lesion load and the degree of severity
of the MS lesions. Additionally, a mean tissue damage score (MTDS) can also be
obtained by averaging TDS over all the lesions:

MTDS = TDL / LL
This mean score provides an estimate of the average severity of abnormal white
matter tissue in the subject's brain.
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[5.3]

GEPCI scores
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R2*c-R2*

MS lesions
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0 (NAWM)

R2* (s-1)
Tissue Damage Score: (for given voxel)
Global measure of brain
(account for Normal Appearing
White Matter):
Tissue Damage Load:

Width

TDL= V ⋅ ∑ TDS

Lesion Load:

Center

N

LL= V ⋅ N

w/c = width / center

Mean Tissue Damage Score:

MTDS = TDL / LL

Figure 5.3 Introduction of GEPCI scores.

To apply Eqs. [5.1] and [5.2], we need to define a method for separating “normal”
brain tissue from MS lesions. This procedure is always ambiguous because lesions
almost never have sharp boundaries. Also, the distribution function of R2* values of
normal WM has a Gaussian type shape. As for any Gaussian distribution, 95% of
R2* values are located around peak center in the interval R2*=R2c*± 1.96σ, and
99% of values are in the interval R2*=R2c*±2.58σ, where σ is the distribution width.
This means that even in the normal brain there are voxels that have “abnormal”
GEPCI scores. Hence separation of tissue into “normal” and “abnormal” is always
somewhat subjective. Visual examination by a neurologist (A.H.C.) of GEPCI and
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standard clinical images from subjects with MS suggested that the threshold of
1.96σ separates most of the MS lesions from normal appearing tissue. We will use
this threshold in this pilot study leaving more detailed examination for future work.
In addition, all the voxels that have R2* below selected threshold and are isolated
(single voxels) or have only one neighbor (hanging voxels) are eliminated from
consideration to reduce influence of noise on our quantitative estimates. Moreover
the characteristics of the main part of R2* distribution could also reveal info on MS
disease (ref NAWM, peak shift). So we also take width, center, and w/c as part of
GEPCI measures.
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Figure 5.4 Illustration of GEPCI score maps obtained from subjects with RRMS and
SPMS. They are made by overlapping colored TDS indices on T1 weighted images.

Figure 5.5 Illustration of lesion load determined by GEPCI compared to FLAIR
image. Left: FLAIR image; Middle: FLAIR image with highlighted lesion area; Right:
GEPCI score map.

5.2.2 Reproducibility of the R2* map
Tissue-specific parameter, R2* (= 1/T2*) is not used as commonly as R2 or R1 in
clinical studies, and is usually considered susceptible to field inhomogeneity. To
ensure that TDS and other GEPCI scores are suitable for longitudinal studies, we
tested the reproducibility of R2* measurement by GEPCI technique.

Experiments are performed on one healthy volunteer and one MS subject with the
same protocol on 1.5 T scanner and 3.0 T scanner respectively. First run: standard
GEPCI acquisition; second run: a consecutive scan immediately following first run;
third run: subject was pulled out from scanner, tilted head while he was lying on the
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table, sent back in the scanner, and then scanned with the same sequence after
careful shimming of the field.

Figure 5.6 GEPCI reproducibility tested on healthy volunteer at 1.5 T scanner.
Images on top shows T1w (S 0 ) images from run 1 to run 3. Histograms at bottom
left show reproducibility of T1w image; histograms at bottom right show
reproducibility of T2*. Blue, red and green points correspond to run1, run2, and
run3 respectively.
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Figure 5.7 GEPCI reproducibility on MS subject at 3.0 T scanner. Images on top
shows T1w (S 0 ) images from run 1 to run 3. Histograms at bottom left show
reproducibility of T1w image; histograms at bottom right show reproducibility of T2*.
Blue, red and green points correspond to run1, run2, and run3 respectively.

Histograms are chosen to characterize the reproducibility of T2* measurements. As
shown in Figure 5.6 and Figure 5.7, T2* histograms show great reproducibility for
all three scans both on healthy volunteer and patient. On the other hand, T1w
intensity histograms show that after tilting head, T1 weighting shifted significantly
due to different distribution of RF coil sensitivity.
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5.3 Bridging the gap between radiological and clinical measurements of
multiple sclerosis using Quantitative GEPCI Scores

5.3.1 Clinical tests
For each visit, patients are scanned with the standard MRI protocol introduced in
Chapter 4, and also evaluated with clinical standard tests. EDSS (Expanded
Disability Status Scale) evaluation is performed by experienced doctors. It is the
“gold standard” for assessing impairment in MS (7). The MS Severity Score, a
measure of aggressiveness of MS, was calculated based on the EDSS and
duration of disease (135). MSFC (Multiple Sclerosis Functional Composite) is less
subjective and more quantitative than EDSS, making it more amenable to statistical
comparisons (136,137). The MSFC measures function, whereas the EDSS is
neurologic examination. MSFC is comprised of timed 25 foot walk (test of
ambulation), 9 hole peg test (test of upper extremity function) and 3 second paced
auditory serial addition task (PASAT). PASAT is a standardized 10 minute test of
information processing speed and attention/working memory, cognitive processes
that are commonly impaired in MS. Since many of our early MS subjects score
normal on the PASAT 3 sec version, we also include the 2 sec version. Symbol
Digital Modality Test (SDMT) is also added in the protocol, it is demonstrated to be
less susceptible to the practice effect than PASAT in measuring cognitive
functions(138).

119

5.3.2 Baseline demographics
Characteristics
Number of subjects
Age. y. median (range)
Gender. F:M
EDSS. median (range)
Disease Duration. y.
MSSS. median (range)

Values
overall
30
51.5 (27 to 70)
16:14
5.5 (1.5 to 8.0)
13 (3 to 34)
5.25 (2.08 to 9.86)

RRMS
10
44 (27 to 52)
6:4
2.5 (1.5 to 6.5)
7 (3 to14)
4.27 (2.60 to 8.31)

PPMS
10
54.5 (40 to 70)
6:4
5.75 (3.5 to 8.0)
9 (4 to 26)
7.11 (2.08 to 9.86)

SPMS
10
52.5 (41 to 64)
4:6
6.0 (4.0 to 6.5)
25.5 (17 to 34)
5.25 (2.99 to 6.39)

Table 5.1 Baseline demographics

A group of 30 subjects - ten subjects each representing RRMS/SPMS/PPMS
clinical subtypes (EDSS ranges 1.5-6.5/4.0-6.5/3.5-8.0) were recruited. The EDSS
scores in each subgroup are chosen to be overlapping as much as possible. The
RRMS group is younger than the other two groups. Since SPMS subjects by
definition is at a fairly late stage of the disease, the disease duration of the SPMS
subjects is much longer than the RRMS subjects.

5.3.3 Correlations in Clinical and Radiological measurements
Since our subject groups is small, and all parameters are not normally distributed,
we used non-parametric Spearman ρ to examine cross correlations both within and
between clinical measurements and traditional imaging measurements and GEPCI
scores (we use the all 30 subjects as one group).

Correlations within clinical scores are shown in Table 5.2. EDSS is shown to highly
correlate with MSSS, which is natural since EDSS is one of the determinants in
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MSSS. On the other hand EDSS correlates poorly with all cognitive tests (PASAT
3'', 2'' and SDMT), suggesting that it reflect little cognitive dysfunctions. Although
EDSS correlate highly with both MSFC 3'' and MSFC 2'', it is plausible to suggest
that this correlation is driven by the 25' walk and 9-HPT components (especially the
25' walk which shows the strongest correlation with EDSS). MSSS and 25' walk
show similar correlation patterns with other parameters as EDSS - poorly correlated
with cognitive tests. MSSS shows weaker correlations with all other tests compared
to EDSS, suggesting that the disease duration component in it does not play much
role in functional tests. PASAT 2'' correlates strongly with PASAT 3'', and they both
show similar correlations with other tests. As composite scores, MSFC 2'' and
MSFC 3'' both find good correlation with all other parameters (except for MSSS).
The 9-HPT test - as the upper extremity component of MSFC - correlated well with
all other parameters, which indicates that this test is not limited to the upper
extremity function.
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EDSS
EDSS
MSSS
PASAT 3’’
MSFC 3’’
PASAT 2’’
MSFC 2’’
SDMT
25’ Walk
9-HPT

MSSS
0.727 *****

PASAT 3’’
-0.420 *
-0.372 *

MSFC 3’’
-0.679 *****
-0.541 ***
0.822 *****

PASAT 2’’
-0.364
-0.179
0.761 *****
0.752 *****

MSFC 2’’
-0.669 *****
-0.463 *
0.705 *****
0.940 *****
0.834 *****

SDMT
-0.359
-0.263
0.703 *****
0.643 ****
0.669 ****
0.652 ****

25’ Walk
-0.866 *****
-0.562 ***
0.339
0.711 *****
0.478 *
0.7235 *****
0.384 *

9-HPT
-0.623 ****
-0.566 ***
0.583 ***
0.854 *****
0.522 ***
0.824 *****
0.545 ***
0.565 ***

Table 5.2 Spearman ρ between Clinical Scores. p: Probability > |ρ|. * p<0.05, ** p<0.01, *** p<0.005, **** p<0.001, ***** p<0.0001.
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TDL

LL

MTDS

Width

Center

TDL
LL
MTDS
Width
Center
w/c

0.977 *****
0.624 ****
0.363 *
-0.284
0.408 *

0.471 **
0.241
-0.250
0.276

0.743 *****
-0.331
0.821 *****

0.096
0.946 *****

-0.175

LL- FLAIR

0.914 *****

0.867 *****

0.669 *****

0.476 **

-0.406 *

w/c

0.546 ***

Table 5.3 Spearman ρ between GEPCI scores. * p<0.05, ** p<0.01, *** p<0.005, ****
p<0.001, ***** p<0.0001.

Correlations within MRI parameters are examined in Table 5.3. GEPCI scores are
aiming to characterize two major features in the diseased brain - lesions and the
brain as a whole. The TDL, LL and MTDS are defined as characteristics of lesion
area. While LL is lesion load volume, TDL is the load of tissue damage weighted by
damage severity. The strong correlation between TDL and LL could be due to the
fact that by definition our TDL is also heavily weighted by lesion load, and the fact
that patients with larger lesion load tend to have more severe damage (especially in
SPMS subjects). The correlation between LL and MTDS also supports that. Global
measures of the brain tissue are supposed to reflect properties of so-called 'normal
appearing white matter (NAWM)', since although many parts of the brain do not show
any abnormality (appear normal) in MRI scans, they have a lot of pathology under
microscope (139). Width show very strong correlation with the MTDS. That could be
partially due to our way of choosing the lesion 'cut-off' - we propose to do it at the
R2*=R2 c * - 1.96σ, this inevitably means that when the width is broader, the lesions
are cut at lower R2*, their mean tissue damage load will be higher. On the other
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hand, center did not correlate with any of the other GEPCI parameters. As the mean
value of the whole brain R2* distribution, the center might be affected by different
factors other than the disease. For example, R2* would increase with iron
accumulation, which is known to happen along the process of aging (140). Also,
while we expect R2* decrease with neuronal tissue loss -> more water in the tissue,
the brain suffers from atrophy at the same time, which reduces the total brain
volume, thus counteracts the decrease of macromolecule concentration in tissue.

We have also calculated the lesion load based on the standard MRI technique –
FLAIR and examined correlations with all GEPCI parameters. Strongest ones are
with TDL and LL, which is expected. The correlation between FLAIR results and
global GEPCI parameters is much weaker.
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EDSS

MSSS

PASAT 3’’

MSFC 3’’

PASAT 2’’

MSFC 2’’

SDMT

25’ Walk

9-HPT

TDL
LL
MTDS
Width
Center
w/c

0.343
0.311
0.176
0.127
-0.017
0.142

0.116
0.104
0.033
-0.162
-0.005
-0.170

-0.314
-0.292
-0.186
-0.083
-0.038
-0.069

-0.524 ***
-0.500 **
-0.298
-0.074
0.088
-0.102

-0.458 *
-0.447 *
-0.283
-0.130
0.004
-0.061

-0.644 ****
-0.630 ****
-0.344
-0.146
0.057
-0.140

-0.444 *
-0.429 *
-0.321
-0.141
0.073
-0.136

-0.461 *
-0.458 *
-0.196
-0.066
0.088
-0.098

-0.454 *
-0.402 *
-0.382 *
-0.166
0.120
-0.193

LL- FLAIR

0.348

0.088

-0.254

-0.455 *

-0.307

-0.544 ***

-0.423 *

-0.405 *

-0.461 *

Table 5.4 Spearman ρ between GEPCI scores, FLAIR and Clinical measurements of disability. p: Probability > |ρ|
* p<0.05, ** p<0.01, *** p<0.005, **** p<0.001, ***** p<0.0001.
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Table 5.4 shows correlations found between radiological and clinical scores. TDL and LL
both correlate with MSFC 3'', MSFC 2'' and each of their components (except for PASAT
3'') and also SDMT, albeit not very strong with most of them. The fact that significant
correlation does not exist between TDL and PASAT 3'' but does exist with the more
sensitive PASAT 2'' indicates that GEPCI has high sensitivity in measuring brain
abnormality. Subsequently, the stronger correlation between TDL and MSFC 2'' than 3''
is driven by the cognitive component. Note that the correlation between TDL and MSFCs
is the strongest among all other scores, indicating that this correlation is not driven by
any single component of MSFC. The lack of correlation between GEPCI and EDSS or
MSSS (though both TDL and LL correlated with 25' walk moderately) show that GEPCI
still in need of elements that assess other parts of CNS to perform more comprehensive
evaluations for MS (same statement holds true for FLAIR-based lesion load count).

TDL did consistently better than LL with all their correlations, indicating that incorporating
severity of lesion in the assessment does allow a stronger relationship between the
radiological findings and functional impairments. No significant correlation is found
between GEPCI global measures of the brain and disability tests. This might be
attributed to the need of GEPCI data correction for magnetic field inhomogeneities which
is a subject of current effort.

The FLAIR based lesion load assessment performs weaker than GEPCI scores (weaker
in every correlation it has except for 9-HPT). We did not find correlation of FLAIR-LL with
either PASAT 3'' or PASAT 2'', but there is some correlation between FLAIR-LL and
SDMT.
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5.3.4 Differentiating MS subtypes based on GEPCI or Clinical evaluations
As shown in the baseline demographics, this patient cohort is chosen to have three
subtypes of MS patients, 10 each. In this section we try to determine how well GEPCI
could discriminate the MS subtypes, and compare it with clinical scores' performance.

To accomplish that, we utilize the 'Decision Tree' method in the partition platform in
JMP® (108). This program is convenient for exploring relationships without having a
good prior model. In our case, the factor variables (X) are continuous, and the response
variables (Y) are categorical (RRMS/PPMS/SPMS). The program recursively partitions
data according to a relationship between X and Y values, creating a tree of splits. It finds
a set of groupings of X values that best predict a Y value. It does this by exhaustively
searching all possible groupings, and find the best among all candidates in X to do one
split. Repeatedly splitting the data results in branches and leaves of the tree.
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RRMS
PPMS

GEPCI

SPMS

Count
Total %
RRMS
PPMS
SPMS

70% correct!

1

2

3

7

4

0

11
36.67

2

4

0

6
20.00

1

2

10

13
43.33

10
33.33

10
33.33

10
33.33

30

Figure 5.8 Decision tree and categorization of MS subtypes resulting from using GEPCI
parameters alone.

First, we put all GEPCI parameters as potential factors to predict 30 subjects' MS
subtypes. As shown in Figure 5.8, the decision tree started splitting by a global
parameter in GEPCI 'width'. The left leaf corresponding to width >= 4.73, has 18
subjects, including all SPMS, 4 RRMS and 4 PPMS; the right leaf corresponding to width
< 4.73, has 12 subjects, 6 RRMS and 6 PPMS. Then the tree grows with utilizing TDL as
another factor. Groups of subjects are further split based on their tissue damage load.
The w/c factor is used at last, but the final split does not affect the grouping results. In
short, GEPCI is able to correctly identify all 10 SPMS subjects, 7 RRMS and only 4
PPMS, which adds up to total of 70% correctly grouped. The SPMS has broad width and
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large TDL as expected; the PPMS group has small width and small TDL, which might be
due to the reason that many PPMS subjects tend to have more lesions in their spinal
cord; the RRMS group however, has either small width and large TDL or broad width and
small TDL. The way RRMS group formed is very interesting. It might indicate that the
inflammations in RRMS brains are highly dynamic processes, or that there are two kind
of pathways for the disease to develop - finally they merge to SPMS (big width, big
lesion). The high number of misclassification in RRMS and PPMS calls for extra
information in GEPCI technique - spinal cord will definitely help! & measurement of brain
atrophy may also improve the technique.

RRMS
PPMS
SPMS

Clinical

Count
Total %
RRMS
PPMS
SPMS

80% correct!
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Figure 5.9 Decision tree and categorization of MS subtypes resulting from using all
clinical parameters.

In Figure 5.9 Decision tree and categorization of MS subtypes resulting from using all
clinical parameters., 80% of all subjects are correctly identified. Among all clinical
measurements, the program chose EDSS and MSSS for the entire grouping (the final
split by PASAT did not affect results). Since the EDSS is the clinical 'gold standard' in
measuring disabilities, and MSSS is result from EDSS and disease duration, they are
expected to be strong in differentiating these MS subtypes. For example, 6 of RRMS and
9 of SPMS are identified by using EDSS alone (<3.5 and >5 respectively); also 6 PPMS
got identified at the high end of MSSS since they progress from the disease onset
without any recover episodes as RRMS.

Considering the fact that these clinical measurements are somewhat already affected
doctor's judgments of MS subtypes, while GEPCI had no such advantages, it performs
quite nicely in grouping MS subjects. Moreover, among 9 misclassified subjects by
GEPCI, and 6 misclassified by EDSS and MSSS, they only have 1 (RRMS grouped as
PPMS) in common, which suggests that the criteria offered by GEPCI and EDSS might
have very different underlying mechanism. Larger sample size is needed for further
validation of our observations.
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RRMS
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39.29
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32.14
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28.57
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Figure 5.10 Decision tree and categorization of MS subtypes resulting from using clinical
parameters excluding EDSS, MSSS and 25' walk.

Figure 5.10 shows results from using only cognitive tests to classify subjects. 21 out of
28 are correctly classified (2 missing values in PASAT 2''). The 7 misclassifications here
also have only one overlapped with GEPCI (a PPMS grouped as RRMS by GEPCI, and
grouped as SPMS by cognitive tests). And there are 3 misclassifications overlapped with
EDSS/MSSS.

131

5.3.5 Summary
In summary, GEPCI offer multiple parameters in evaluating brain abnormality. TDL
incorporates tissue damage severity in lesions; Lesion load provided by GEPCI scores
correlate highly with clinical standard imaging FLAIR; GEPCI also provides measures
beyond the lesions - distribution width and center assess changes in the NAWM. Among
correlations between GEPCI and clinical tests, TDL and MSFC 2'' is the strongest
(Spearman ρ = -0.644), and it's not driven by single component in MSFC. Both TDL and
LL perform slightly better than FLAIR-LL. Although NAWM measures do not show
correlations with clinical disability measurements, the 'width' does help with
differentiating MS subtypes. GEPCI alone was able to correctly group 70% of all
subjects, while EDSS/MSSS did 24/30, and cognitive scores did 21/28. This is not
possible by using FLAIR-LL alone.

Although it remains a huge challenge to relate brain tissue damage in MR imaging to
patients’ clinical manifestations, compared to standard MRI scans, GEPCI is a big step
forward in filling the gap between clinical and radiological measures.

5.4 Preliminary results of GEPCI in Spinal Cord Imaging5
As an important part of the CNS evaluation, spinal cord imaging is valuable in both
diagnosis and ongoing evaluation of patients with multiple sclerosis (MS) (141).
However, assessment of spinal cord damage using MRI lags behind the development of

5

All contents have been published in Luo J, Cross AH, Yablonskiy DA. Quantitative evaluation of spinal cord tissue
damage in MS patients using Gradient Echo Plural Contrast Imaging. Proc. Intl. Soc. Magn. Reson. Med. 2011; 2176.
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brain methodology. Given GEPCI technique promise to provide substantial improvement
in image quality and MRI acquisition time as compared to clinical sequences, and has
already been used to quantitatively evaluate white matter tissue damage in brains of MS
patients (40), it is tempting to use GEPCI technique to discriminate tissue damage in
spinal cord of MS patients against normal subjects. This is an important step in
development the GEPCI technique as a comprehensive tool for quantifying the extent of
tissue damage of the whole CNS, and monitoring MS disease progression. Herein we
provide preliminary results obtained in this direction.

Methods and Data Analysis: Data from the cervical spinal cord of healthy volunteers
and relapsing-remitting MS patients were acquired using a Siemens® 3.0T Trio MRI
scanner. A 3D version of GEPCI sequence was used with high isotropic resolution of
1x1x1 mm3 and 11 gradient echoes (8min32s acquisition time). Further effective
resolution enhancement was achieved with zero-filling in the k-space. A set of five
standard clinical 2D turbo spin echo T1w and T2w images were acquired with a total
imaging time of 16 min. Saturation band was applied on the anterior portions of the
torso, to suppress motion artifacts. GEPCI technique simultaneously generates naturally
co-registered quantitative T2* and R2*=1/T2* maps, along with T1-weighted (T1w)
images. Data were analyzed using Matlab®. Isotropic resolution allows image
reconstruction in arbitrary plane, thus providing great advantages over clinical methods.
Mask for spinal cord area including both white matter and gray matter was obtained with
segmentation based on the T1w-GEPCI images. R2* histogram of the whole cord is
generated using a bin width of 0.3 s-1 ranging from 0 s-1 up to 30 s-1.
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Results and Discussion:

Figure 5.11 Examples of GEPCI-T1w (left column), T2* map (middle column) and R2*
map (right column) of the spinal cord. Bottom row is the sagittal view; Upper row magnified views of the transverse cut through the spinal cord corresponding to the red
line on the sagittal view. All images are reconstructed from the same GEPCI 3D data set.
The image on the right represents anatomy of spinal cord at a similar level;

In Figure 5.11, characteristic butterfly pattern of the grey matter is clearly seen on axial
GEPCI R2* map. Remarkably, the grey matter is also seen on the sagittal views (bright
T2* / dark R2* lines inside the spinal cord).
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Figure 5.12 Examples of the R2* histograms of c-spinal cord of a healthy control (left)
and MS subject (right).

In Figure 5.12, the width of the distribution (variation of the R2* values) of RRMS subject
(12.9 s-1) is substantially greater than the R2* variation of control subject (8.32s-1)
suggesting diffuse MS tissue damage.

Figure 5.13 Images of an MS patient. Standard T2-weighted image is shown on the left;
GEPCI score map is shown on the right.
We can clearly see 2 lesions on the clinical T2-weighted image (left) around C1 and C2
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area. Lesions on GEPCI image (right) showed up at similar positions.

TDS (tissue damage score) of MS lesions was generated based on the R2* distribution
shown in Figure 5.12, which indicates relative severity of the lesions. It was
subsequently overlapped on the naturally co-registered GEPCI-T1w image. Definition of
the lesion score here is analog to what was done for the MS brain lesions (see 5.2.1
Tissue Damage Score)

Spinal MS lesions are rarely depicted as hypointense on clinical T1w images, which
indicates that the pathological changes in the tissue are not sufficient to produce
contrast in T1w images (141). Similar situation is seen in our GEPCI-T1w image.
However, quantitative R2* histograms shown in Figure 5.12 clearly differentiate normal
from MS tissue. One of the problems with the clinical standard T2/T1 weighted images is
that the intensity of the image is affected by the RF coil sensitivity and homogeneity of
the RF field. Indeed we also observe image intensity variation (both up-to-bottom and
left-to right) in our T1w images (Figure 5.11, left). However, as seen in Figure 5.11
(middle and right), the R2* and T2* GEPCI maps, being quantitative, are exempt from
the sensitivity problem.

In summary: In this section, we demonstrated the capability of extending GEPCI
technique to spinal cord imaging in general and quantitative evaluation of tissue damage
in MS. High quality images were collected twice faster compared to standard clinical MS
protocols. As a quantitative technique, GEPCI holds promise toward comprehensive
characterization of MS abnormalities in the spinal cord. Also note that the cerebellum
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and brain stem areas showed very good contrast with our resolution, which further
strengthens the promise for GEPCI technique to characterize the whole CNS.

5.5 Preliminary Results of GEPCI with Detecting Cortical Lesions in Ex Vivo MS
Brain 6
Although most imaging research in Multiple Sclerosis has focused on the white matter,
pathology can also be found in gray matter, including cerebral cortex. MS symptoms and
signs including cognitive impairment, fatigue, and seizures have been linked to gray
matter involvement (111). Conventional MRI techniques that are routinely used to detect
MS lesions are T1 and T2 weighted spin-echo images and FLAIR, which detect white
matter lesions well, but miss most cortical lesions, as reported in a postmortem tissueMRI correlation study (142) at field strength of 1.5 T. Though higher fields will result in
increased detectability of both cortical and WM lesions (143), these imaging techniques
will suffer from high specific absorption rate (SAR), especially at 7.0 T. GEPCI on the
other hand, is a technique based on multi-echo gradient echo sequence, which has very
low SAR. In this pilot study, we evaluated GEPCI as a way to detect and quantify cortical
lesions.

Material and Methods: Acquisition: Brain tissue of an ex vivo MS patient was scanned
on a Varian 4.7 T MRI. Sample prepared as figure on the left. A 3 cm diameter bird cage
coil was used to obtain a 3D version of the multi-echo gradient echo sequence with a

6

All contents have been published in Luo J, Cross AH, Schmidt R, Sukstanskii AL, Yablonskiy DA. Detecting cortical
lesions in MS tissue with Gradient Echo Plural Contrast Imaging. Proc. Intl. Soc. Magn. Reson. Med. 2012; 3123.
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resolution of 0.11 x 0.11 x 0.5 mm3, FOV of 40 x 40 x 8 mm3 and 8 gradient echoes (TR
= 200 ms; minTE = 4.58 ms; delta-TE = 7.6 ms; bandwidth = 40 kHz/FOV; FA = 60°,
acquisition time = 13 min). 2D T2 weighted images were also acquired with spin echo
sequence at different TE separately, (TR = 4000 ms; TE = 13 ms, 50 ms; acquisition
time = 8 min x 2) and slices of same orientation.

Figure 5.14 Demonstration of tissue sample and experimental set-up.
Image Analysis: GEPCI data were analyzed assuming mono-exponential signal decay
and attenuation due to macroscopic field inhomogeneities, describing by F-function as

S0 ⋅ e
discussed in (6): S (TEn ) =

− R 2*⋅TEn

⋅ F (TEn ) . The fitting to magnitude data produces

two naturally co-registered basic GEPCI images: quantitative T2* = 1/R2* map and T1weighted images (S 0 ). The frequency maps are obtained from phase data and used for
calculation of F-function (6). As for T2 mapping, T2 weighted images at two echo times

) S0′ ⋅ e
were fit by a mono-exponential decay: S (TEn=

− R 2⋅TEn

, which results in a T2=1/R2

map and a Spin Density image ( S0' ). All data were Hann-filtered to improve SNR before
fitting procedures.
Results & Discussions: As shown in Figure 5.15, T2* map, T1-weighted image and T2
map showed very well defined cortical lesion (red arrows). Sub-cortical structures are
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also observed on GEPCI images and T2 map. The contrasts in cortical structures are
not seen on the Spin Density images. It has been reported that focal cortical lesions are
often extensive in MS (46). Unfortunately, cortical lesions are often completely missed
with conventional MRI techniques, due to limited signal contrast between cortical grey
matter and lesions. Double Inversion Recovery (DIR) has been reported to have
significantly improved detection of cortical lesions (142), but it is often difficult to
distinguish true lesions from artifacts using DIR, and problems are anticipated with high
energy deposition at high field.

GEPCI-T2* map

GEPCI-T1w

T2 map

Spin Density

Figure 5.15 Results of GEPCI technique and T2 mapping.

In summary: In this pilot study, we have demonstrated that GEPCI technique is
sensitive to cortical lesions and sub-cortical structures on ex vivo MS tissue. GEPCI
holds much promise for the future, as the multi-echo gradient echo sequence upon
which GEPCI is based has no problem with energy deposition at high field and it is very
rapid; one would have to trade off resolution and/or SNR significantly to creates maps of
T2 with similar amount of time.
[
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Chapter 6 Mapping of Phase – Application of GEPCI to
monitoring Multiple Sclerosis 7

6.1 Inconsistency between magnitude image and phase image of MS brain.
6.1.1 Overview
MRI has played a revolutionary role toward enhancing knowledge in biology and
medicine. Numerous MRI techniques have been developed over the years to aid
physicians and scientists in understanding tissue structure and function in health and
disease. One MRI technique that has been of increasing interest in recent years relies
on phase images obtained by GE (gradient echo) MRI. It was demonstrated that phase
images provide image contrast distinct from T1 weighted (T1W) and T2 weighted (T2W)
images (e.g.(3,42-45,144)). However the sources of phase contrast have not been
completely understood and are a subject of intense debate. Myelin was proposed as one
of the main contributors to MR signal phase in white matter (145) and it was
demonstrated that demyelination leads to a loss of phase contrast between white matter
(WM) and gray matter (46) (54,146). This could have been explained by the difference in
tissue cellular/molecular content (iron, lipids and proteins) between GM and WM. Yet it
was also reported that phase contrast is practically absent between WM and CSF
(3,144) despite substantial differences in their molecular content. Iron was shown to play
an important role in formation of phase contrast in iron-rich areas such as caudate,

7

All contents in this chapter have been accepted for publication in Yablonskiy DA, Luo J, Sukstanskii AL, Iyer A, Cross
AH. Mapping MRI signal frequency to reveal central nervous system damage: biophysical mechanisms and application to
multiple sclerosis. submitted to Proc. Natl. Acad. Sci. USA.
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putamen, and globus pallidus (69,147-149). However, experimental data on the role of
iron in WM is controversial – while a decrease of the phase contrast after iron extraction
from the fixed brain tissue was reported in (145), this effect was not seen in (54). It was
also concluded in (60) that the MR phase contrast between cortical gray and white
matter can be mainly attributed to variations in myelin content, but not to iron
concentration. Similar uncertainty exists in the study of multiple sclerosis (MS) using
phase imaging, one of its emerging applications. In initial publications (148,150,151), a
variety of manifestations of MS lesions in phase images were reported. It was noted that
some lesions seen on phase images were also seen on T1W and T2W images, but
some alterations were unique to phase images. Also some lesions detected on T1W and
T2W images were not seen on phase images. One hypothesis proposed to explain
phase contrast is based on an assumed mechanism that relates MR signal
phase/frequency shift to iron content in the tissue. (148,150,151) However this
mechanism does not take into account the hallmarks of MS lesions - the loss of axons
and myelin (10).

Bridging the gap between these controversial findings is one of the main goals of this
Chapter. To this end we provide theoretical background to the hypothesis that the local
contribution to the MRI signal phase depends not on bulk tissue content but on tissue
“magnetic architecture” - distribution of magnetic susceptibility inclusions (lipids,
proteins, iron, etc) at the cellular and sub cellular levels (144). This allowed us not only
to shed new light on the above-mentioned controversies but also to propose a theory of
MRI phase contrast in MS. We demonstrate herein that according to this mechanism,
phase contrast in MS lesions could appear simply because of injury to the myelin
sheath, even without its removal from the affected area, thus preserving bulk tissue
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magnetic susceptibility. Our theoretical concept indicates that phase contrast is sensitive
to mild lesions, and thus may appear abruptly at lesion onset when damage is still
minimal. Our preliminary data in several human subjects show abnormalities seen only
on phase and not magnitude images, within the areas with borderline abnormal tissue
damage, which can be explained by our theoretical prediction that the phase contrast in
MS lesions could be altered with mild injury to the myelin sheath or axonal
neurofilaments. Hence these phase abnormalities may represent mild or early MS
lesions. Contrary to a common-sense expectation that the phase contrast in MS lesions
should always increase in degree along with worsening of lesion severity (as happens
for all known MR magnitude-based contrast mechanisms), we demonstrate that phase
contrast can actually disappear in situations of medium to severe tissue destruction.
Moreover, we predict that the sign of phase contrast in MS lesions indicates the
predominant type of tissue injury – myelin damage (positive sign) vs. axonal
neurofilament damage (negative sign). In the current paper, we provide theoretical and
experimental evidence supporting these mechanisms of phase contrast in MS lesions.
Our findings have potential to expand the information provided by CNS imaging both for
understanding MS pathophysiology, and as an endpoint in clinical trials (152).

6.2 Phase Contrast in MS brain – Theoretical predictions
6.2.1 Phase Contrast in White Matter - Theory
Tissue magnetic architecture at the global (organ or body part) and at the cellular/subcellular levels depends on the structural (geometric) arrangement of the main tissue
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components (proteins, lipids, iron, etc) that, as far as MRI is concerned, act as magnetic
susceptibility inclusions. In an external magnetic field B 0 magnetic susceptibility
inclusions become magnetized and induce their own magnetic fields that affect (shift)
Larmor resonance frequencies of water molecules. White matter structure can be
described as mainly comprised of quasi-cylindrical myelinated axons. The induced
magnetic field in these axonal bundles (tracts) is generated by several sources: (a)
longitudinally arranged myelin sheaths and intra-axonal neurofilaments that run mostly
parallel to the axonal tract axis, (b) isotropically distributed free floating organelles,
proteins, lipids, etc., and (c) the interface between the white matter tract and the
surrounding tissue.

In a GE experiment, the contribution of each water molecule, diffusing in the
inhomogeneous magnetic field, to the MR signal at GE time TE can be represented as
TE

exp(iϕ (TE )) where ϕ (TE ) = γ ∫ b( r (t ))dt is the phase accumulated by the diffusing
0

molecule along its trajectory r (t ) ; b( r (t )) is a projection of the local magnetic field,
created by all the sources of magnetic field inhomogeneities at point r (t ) , on the
external magnetic field B 0 . According to well known results followed from Maxwell
equations, the distribution of magnetic fields in the cylinder-like structures depends
mostly on the position in the transverse plane. Since in white matter water molecules are
confined either to intracellular or extracellular spaces with the transverse sizes about or
less than 1 µm, it requires less than 1 ms to sample the whole distribution of magnetic
field within a given compartment (water diffusion coefficient is about 1 µm2/ms). Hence
for gradient echo time TE greater than 1 ms used in experiments, all diffusing nuclei in
the same compartment sample the whole distribution of magnetic fields within a given
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compartment and, therefore, accumulate similar phases (motional averaging regime).
Effectively, a diffusing water molecule “feels” an average magnetic field

bm

in the

compartment where it resides, hence

ϕ m (TE ) = 2π ∆f mTE ; 2π ∆f m = γ bm

[6.1]

where ∆f m is an average frequency shift in m-th compartment. Based on this
consideration, only an average magnetic field in each compartment should be
calculated. In what follows, we will use Eq. [6.1] and computer Monte-Carlo simulations
to quantify influence of WM microstructure on MR signal phase. For this purpose we will
initially use a simple model of axonal structure presented in Fig. 1.

6.2.2 Monte-Carlo Simulations of Phase Contrast in Intact and Destructed
Tissue

Figure 6.1A represents a schematic structure of an intact myelinated axon (intracellular
water, myelin sheath and extracellular water). Computer Monte-Carlo simulations of the
MR signal frequency shift were performed in the intact myelinated axon and in an axon
undergoing demyelination typical of MS (Figure 6.1B and C). The latter was modeled by
fragmenting the cylindrical structure of the myelin sheath to different degrees. The
fragments were modeled as spheres with positive magnetic susceptibility with respect to
water (because lipids and iron each provide a positive magnetic susceptibility, whereas
proteins have a primarily negative contribution (144)). The phase accumulated by
diffusing water molecules was calculated based on the well known expressions following
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from Maxwell equations for magnetic field created by cylinders and spheres (see for
example (72)).

Figure 6.1 Effect of increasing myelin sheath damage on phase/frequency of MR signal
derived from computer Monte-Carlo simulations. A) schematic of an intact axon (internal
cylinder) covered by a myelin sheath (bold outline of cylinder) in an extra-cellular space
(between bold and outer cylinder) with radius R 0 . B) “Mildly” damaged myelin sheath –
fragments of original structure are slightly scattered. C) “Severely” damaged myelin
sheath - fragments of initial structure are scattered randomly. Lower panel -dependence of the Lorentzian Factor (LF) in the MR signal frequency shift on the “level
of distraction” (δR – average fragments’ displacement). Shaded zone (0-0.2) indicates
minor injury to tissue, wherein even a small increase in the “disorder” parameter δR
(horizontal axis) will rapidly and dramatically change the Lorentzian Factor, and hence
will also change signal phase/frequency.
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The calculations revealed that for all the structures in Fig. 1, the water MR frequency
shift could be described by the following equation:

∆f f 0 =LF ⋅ χ

[6.2]

where χ is a total (bulk) volume magnetic susceptibility of inclusions (myelin sheath
and/or its fragments). The proportionality coefficient LF (referred hereafter as “Lorenzian
Factor”) varies with different levels of damage to the myelin sheath. Note that the
Lorentzian Factor is equal to 4π / 3 only for randomly scattered fragments; this case is
usually referred to as a Lorentzian Sphere approach (e.g., (62)). For all other cases, LF
is less than 4π / 3 , approaching zero for the intact axon. Therefore, as previously
suggested (144), the Lorentzian sphere approach is not valid for describing the magnetic
susceptibility frequency shift in normal WM which is highly directional.
An additional factor that contributes to the frequency shift is the object’s (axonal) general
external shape:

∆f f 0 shape =
SF ⋅ χ

[6.3]

For the structure in Fig. 1, where B 0 is parallel to the axonal axis, the shape factor SF,
Eq. [6.3], is zero and the frequency shift is completely determined by the Lorenzian
Factor LF, Eq.[6.2].

The results of Monte-Carlo simulations for an oblique direction of an axon with respect to
magnetic field B 0 are shown in Fig. 2. An important conclusion from this figure is a
prediction of zero frequency shift for the intact axon, regardless of axonal orientation.
146

This important result is due to cancellation of contributions from Lorentzian Factor
characteristic for longitudinal structures, LF longitudinal
= 2π ⋅ sin 2 α (144), and the shape
factor for circular cylinder, SF

cylinder

=
−2π ⋅ sin 2 α . At the same time, for a scattered case

(C), the Lorentzian factor is equal to 4π / 3 and does not depend on axonal orientation,
whereas the shape factor does.

Figure 6.2 Dependence of MR resonance frequency shift, derived from computer MonteCarlo simulations, on the angle α (in degrees) between axonal direction and the external
magnetic field B 0 for an intact axon (A) and randomly-scattered myelin fragments (C).

Figure 6.1 and Figure 6.2 present results for a simplified case when only intact or
damaged myelin sheath contributes to a susceptibility-induced MR signal phase shift.
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The true situation is more complicated due to the presence of components in addition to
myelin and will be discussed below. However, the contribution from proteinaceous
neurofilaments is qualitatively similar (though with the opposite sign) because they are
also organized in longitudinal structures.

6.2.3 Theoretical Predictions of Frequency Shift between Intact Axon and
Surrounding Tissue – Effect of WM “Darkness”
To understand phase contrast in injured MS tissue, we first need to understand phase
contrast in a normal brain. In general, the intact myelinated axon can be described as
comprised of longitudinal structures with magnetic susceptibility χ L (myelin and
neurofilaments) aligned along the axonal axis, and isotropic components (free floating
organelles, proteins, lipids, etc) with magnetic susceptibility χ i . Hence, the total
“Lorentzian contribution” to the MR signal frequency shift is a combination of the two:

4
∆f f 0 Lorentzian = 2π ⋅ χ L ⋅ sin 2 α + π ⋅ χ i . For a circular cylindrical myelinated axonal
3
bundle (tract) surrounded by an isotropic media (like CSF or gray matter) with magnetic
susceptibility χ e , the contribution from the interface (tract shape factor SF) between the

= ( χ L + χ i ) is the
tract and the media is equal to −2π ⋅ sin 2 α ⋅ ( χWM − χ e ) , where χWM
total susceptibility of WM. Thus, the total frequency difference between a circular
cylindrical axonal tract and the external media can be written as

4 

∆f f 0 axon = −2π ⋅ sin 2 α + π  ⋅ ( χ i − χ e )
3 


[6.4]

Note that for non-circular cylindrical tracts this dependence is more complicated (144).
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The fact that the longitudinal structures (myelin sheaths, neurofilaments, etc.) do not
contribute to the total frequency shift of the cylindrical axon when magnetic field B 0 is
parallel to the axonal axis is a direct consequence of Maxwell equations: the induced
magnetization of long cylindrical structures parallel to B 0 does not create any magnetic
field outside the structures themselves. This is not true when B 0 forms an angle with the
axonal axis. However, the average magnetic field contributing to the frequency shift
around intact myelin sheath (or neurofilament) is zero for an arbitrary orientation of B 0
with respect to the axonal axis. Monte-Carlo simulations (see Figure 6.2) confirm this
result, which is also in agreement with published predictions (144).

One of the important consequences of Eq.[6.4] is that the terms proportional to χ L
cancel each other for circular cylindrical axonal bundles, i.e. the longitudinal structures
do not contribute to frequency contrast between such a bundle and any adjacent
isotropic media. Therefore, in the regions of the brain, such as the cortex, where gyri and
sulci abut one another, the intact cylindrical axons in gyri should have very small
frequency shifts relative to CSF in the sulci. This effect, first predicted by He and
Yablonskiy (144), is counter-intuitive because there is a substantial difference between

= χ L + χ i ) and that of CSF ( χ e ). One
the total magnetic susceptibility of WM ( χWM
could, therefore, expect a substantial phase contrast between WM and CSF. However,
according to Eq. [6.4], the frequency shift is determined not by the difference ( χWM − χ e )
but the difference χ i − χ e , where χ i comprises a small fraction of the total magnetic
susceptibility of WM χWM , leading to very little contrast between WM and CSF (144).
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In the same manner, Eq. [6.4] also explains negative WM/GM contrast which is also
counterintuitive because WM has higher magnetic susceptibility than GM (144).
However, according to Eq. [6.4] the phase/frequency contrast between WM and GM is
proportional to χ i − χ GM , which is essentially magnetic susceptibility of GM (with the
negative sign) since χ i comprises only a small fraction of the total magnetic
susceptibility of WM. These results are in agreement with previous observations (3,144)
where the dominant “bright” regions in phase images belong to GM, while WM and CSF
are usually dark. Exceptions are areas of high concentrations of iron, e.g. caudate nuclei
(148). Such a dark background provides a convenient display for MS lesions that have
mostly (but not always) positive phase (see examples in Figure 6.3) due to the effect of
myelin “disordering” in MS.

6.2.4 Theoretical Predictions – Frequency Shifts in MS Tissue
An essential feature of the plot in Figure 6.1 generated by computer simulations is the
steep growth of the LF predicted to occur with only minor damage to the myelin sheath
(shaded zone). Thus, even small abnormalities in MS-affected CNS may cause
substantial (positive in sign) changes in MR signal phase. A theoretical consideration for
axonal damage (destruction of neurofilaments) leads to a similar scenario with one
important difference – phase/frequency as a function of neurofilament destruction
experiences negative changes. This is because neurofilaments are formed from proteins
that have a negative magnetic susceptibility with respect to water, whereas myelin is
>70% lipid and also contains relatively more iron, each having positive susceptibility with
respect to water (144). Since frequency shift in Eq. [6.2] is a product of two factors – LF
and tissue magnetic susceptibility ( χ L in this case), one can expect that with tissue
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destruction, phase will experience major changes for mildly damaged longitudinal
structures due to the steep increase in LF. On the other hand, decrease in tissue
magnetic susceptibility due to tissue removal from the damaged area may lead to
reduction of phase/frequency changes for severely damaged tissue. To characterize
tissue damage in MS we use a previously introduced (40) quantitative parameter –
tissue damage score (TDS). TDS around zero corresponds to normal tissue and TDS =1
corresponds to severely injured tissue (‘black holes”). Both TDS and MRI signal
frequency/phase are obtained herein using gradient echo plural contrast imaging
(GEPCI) technique (39) which is described in the ‘experimental results’ section in 6.3.

Importantly, the sign of phase/frequency changes depends on the type of injured tissue
(axonal filaments vs. myelin). With myelin damage and intact neurofilaments, the change
is positive, whereas in the case of damage to proteinaceous neurofilaments within intact
myelin the change is negative. This scenario is depicted in Figure 6.3. However, the
latter case would typically occur in the setting of myelin destruction with a possible
additional components of lipids and iron which would offset the negative phase change.
This is consistent with our and others (151) observation of negative phase changes in
MS lesions being very rare.

Figure 6.3 Schematic structure of the MR signal phase/frequency change with MS lesion
severity for two types of tissue destruction: left panel – pure myelin injury, right panel –
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pure injury to neurofilaments. Minimal myelin injury which may not be apparent on
standard T2W and T1W images will appear positive by phase, corresponding to the
initial ascending portion of the left figure (and also lower panel Figure 6.1). For
moderately severe lesions with predominant myelin injury (center of the left figure,
medium TDS score), phase will also be positive. However, axon destruction is often also
present, and the relative degree of myelin and neurofilament destruction will affect the
sign of the phase change. Severe lesions such as persistent black holes, with a high
TDS score and significant destruction of both myelin and axons might disappear on
phase images.

Based

on

the

above

consideration,

the

following

scenario

describes

MRI

phase/frequency behavior according to the type and severity of MS tissue damage.
(i) Normal WM, having mostly longitudinal structure, has little local effect on MR signal
phase.

(82) At the initial stages of MS lesion development with demyelination, small alterations
in this longitudinal structure would become visible on phase images. This might happen
even before detection using other techniques. Hence, MR signal phase might serve as a
very sensitive biomarker for minimal abnormalities or early MS lesion development.
Importantly, damage to myelin would cause an increase in signal phase (positive
contrast), while damage to axons would cause a decrease of signal phase (negative
contrast). When axons degenerate, the surrounding myelin is also subsequently lost due
to Wallerian degeneration. Thus, one would expect negative phase contrast to be
relatively uncommon. If both myelin and axons are damaged, the phase contrast could
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disappearbecause myelin and protein-based neurofilaments have opposite magnetic
susceptibilities resulting in opposing frequency shifts.

(iii) For severely injured tissue, when cellular components (macromolecules) are
removed from the site, magnetic susceptibility becomes small leading to decreased
phase contrast. Hence for many cases with medium and severe damage, one can
expect very small phase contrast. This can explain previous reports of phase changes
being detected only for a subset of MS lesions (see for example (148,150)).

6.3 Phase Mapping in MS - Experimental Results
6.3.1 Materials and Methods
Image Acquisition: Brain images were collected using a Siemens 3T Trio MRI scanner
(Erlangen, Germany) and a 12-Channel phased-array head coil.
GEPCI data were obtained using a 3D version of the multi gradient echo sequence with
a resolution of 1x1x3 mm3, FOV of 256 mm x 192 mm and 11 gradient echoes (TR=50
ms; First TE=4ms, δTE=4 ms; FA=30°). To generate GEPCI images raw data were
reconstructed using Eq.[4.5]. The frequency maps were high-pass filtered to remove
effects of macroscopic field inhomogeneities using a 7x7 (out of 256x256) in-plane
averaging matrix. Image reconstruction and post-processing were performed using a
standard PC computer and Matlab software (MathWorks Inc.). The automatic shimming
procedure available on the Siemens scanner allowed substantial minimization of
macroscopic field inhomogeneity effects in most parts of the brain. Hence, a simple
fitting of the mono-exponential to the GEPCI signal was sufficient to generate GEPCI
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T2* and T1W images. GEPCI-FST2Star images that are R2* maps with suppressed
signal from CSF and GEPCI T1f images (a combination of GEPCI T1W and frequency
maps) with enhanced GM/WM contrast (39) were also created.
Standard clinical images were also obtained: Forty-four contiguous 3-mm axial imaging
sections were obtained with a 24-cm field-of-view (FOV), a matrix size of 256 x 192, and
using two types of Turbo SE (TSE) sequences: 1) T2-weighted images with TR = 6800
ms and TE = 95 ms, Bandwidth=151 Hz/Px, Turbo factor=7; 2) FLAIR images with TI =
2310 ms, TR = 10000 ms and TE = 83 ms, Bandwidth=219 Hz/Pixel, Turbo factor=13; 3)
T1-weighted images using a standard SE sequence with TR = 600 ms and TE = 12 ms,
Bandwidth=130 Hz/Pixel; Total time for these three standard sequences was 16
minutes.

Human Subjects: The human studies were approved by the Washington University IRB.
One normal healthy subject, four subjects with relapsing remitting MS (RRMS) disease
(gender/age/EDSS = M/42/1.5, M/52/3.5, M/39/2.5, F/42/2.0) and one with secondary
progressive (SPMS) disease (gender/age/EDSS = F/49/6.5) (5,153) entered the study.
Sixty lesions were studied by GEPCI magnitude and phase, and standard imaging.

6.3.2 Experimental Results
Example in Figure 6.4 shows one MS lesion that has a range of tissue damage scores
(TDS) from normal on periphery to severe damage at the lesion center. On FLAIR image
it manifests itself as a bright ring with a dark core. The appearance on GEPCI frequency
map is similar to the appearance on FLAIR though the abnormality is bigger in size and
is surrounded by two dark strips. The sign (positive frequency – myelin damage) and
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pattern of phase changes as compared to GEPCI TDS score are in agreement with our
prediction that phase/frequency becomes abnormal for mildly damaged tissue (blue
TDS), grows with the level of tissue injury and disappears for highly destroyed tissue
(lesion core – red TDS). Dark areas on the GEPCI frequency map might correspond to
predominantly axonal damage while bright areas – to predominantly myelin damage.

Figure 6.4 Example of a MS lesion (marked by a red rectangle) that has a range of TDS
represented by colors on vertical bar. TDS is overlaid on T1f image. Data obtained from
a subject with RRMS (female, age 42, EDSS 2.0).

Examples of changes in phase image in MS lesions with no or very small TDS scores
are shown in Figure 6.5, orange and blue rectangles. These might represent changes in
tissue microstructure that are not observed with conventional imaging techniques. The
positive phase contrast indicates myelin damage.
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Figure 6.5 Example of data obtained from a subject with SPMS (female, age 49, EDSS
6.5). Note the prominent contrast between GM and WM on GEPCI T1f image as
compared to other images. Rectangles outline abnormalities observed on FLAIR or
Frequency (phase) maps. Orange rectangles denote an alteration seen in phase images
(bright contrast) but not on T1W, FLAIR or GEPCI FST2*. This may represent a very
mild lesion with damaged myelin, and is also seen on GEPCI T1f image as negative
dark contrast. Blue rectangle outlines a small MS lesion that is barely seen on FLAIR
and GEPCI FST2*, and is also visible on the phase image. Red rectangle outlines a
severe MS lesion (very high TDS score) that is seen on T1W, FLAIR and GEPCI FST2*
but does not have a footprint on the phase image. A magnified view of this lesion is
shown in the inset (upper right of GEPCI T1f image) with overlaid GEPCI TDS score in
color according to the color bar.

According to Figure 6.1 and Figure 6.3, the phase contrast in severe lesions (black
holes, high TDS score) can disappear even though these lesions would have
substantially different magnetic susceptibility from the surrounding normal WM. Example
of such a lesion is shown in Figure 6.5, red rectangle. The absence of phase contrast
together with high TDS in this case suggests that myelin and axonal debris are mostly
removed from the lesion area.
Lesions of intermediate severity (intermediate GEPCI TDS score) appear on – GEPCI
T1W (hypointense), FLAIR and GEPCI FST2* (hyperintense) and Phase/frequency
maps. Several examples are shown in Figure 6.6, red rectangles. The combination of
TDS and phase appearance suggests that myelin is damaged but with myelin debris still
present in the lesion area. At the same time the lesion denoted by an orange oval has
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similar TDS but very little phase contrast, suggesting damage to both myelin and axon
that offset one another.

Figure 6.6 Example of data obtained from a subject with RRMS (male, age 52, EDSS
3.5) showing multiple lesions (red rectangles) with intermediate TDS scores (overlaid on
GEPCI T1f image). Here, lesions seen on FLAIR are also seen on GEPCI T1W, GEPCI
FST2* (GEPCI analog of FLAIR) and GEPCI Frequency map. Area within orange oval
also corresponds to intermediate TDS with low phase contrast.

The theory of MS lesion manifestations on phase/frequency images proposed herein
should be complemented by considerations of lesion shape, not only the internal lesion
structure. Development of lesions of varying severity might lead to multiple appearances
on phase images, because phase is a combination of multiple factors that include not
only the change in tissue content and structure but also the shape and the structure of
the surrounding tissue. One potential approach to overcoming this problem is
Quantitative Susceptibility Mapping (QSM) (123,125-127,146), where non-local effects of
magnetic fields on phase image are removed by solving Maxwell equations for field
distribution on a global level. The current state of this approach however assumes that
MR signal phase relates to tissue magnetic susceptibility by means of a Lorentzian
sphere approximation which is not the case for WM in general, and MS lesions in
particular, as shown in the present study. Thus, QSM technique, as a tool for analyzing
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WM structure and MS lesions, awaits incorporation of a non-spherical Lorentzian
relationship between MR signal phase and local magnetic field.

In this chapter we focus our attention on the most pronounced injuries to tissue in MS myelin and axonal damage. Other components of the MS lesion, e.g. inflammatory cell
infiltration, gliosis, and edema/increased extracellular space can also be incorporated in
our model. These will be a subject of our future research. Other hypotheses of phase
contrast that were also discussed previously include frequency shifts induced by watermacromolecule exchange in the tissue (42,55,56) and possible tissue magnetic
susceptibility dependence upon orientation with respect to the magnetic field B 0
(58,154), though their roles are not yet clear.

6.4 Summary
In this study we propose a theory of phase contrast in MS and provide experimental and
Monte-Carlo simulated results supporting our theoretical predictions. Our theory is based
on the newly introduced concept - Generalized Lorentzian Approach – that allows
relating MRI signal phase not to tissue bulk magnetic susceptibility but to tissue
“magnetic architecture,” the distribution of magnetic susceptibility inclusions (lipids,
proteins, iron, etc) at the cellular and sub cellular levels (144). Our theory predicts that
the phase contrast in MS lesions could appear due to MS pathology affecting white
matter integrity, such as mild injury to the myelin sheath or neurofilaments, even with
preserved tissue magnetic susceptibility. Also, contrary to an expectation that the phase
contrast in MS lesions should always increase in magnitude with lesion worsening (as
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happens for all known MR magnitude imaging contrast mechanisms), our theory and
experimental results indicate that phase contrast can actually disappear with extreme
tissue destruction. We also demonstrate that the change in the phase contrast might be
specific to a type of tissue injury – myelin (positive change) vs. neurofilaments (negative
change). The GEPCI approach, providing simultaneous information on tissue signal
phase, T2* and T1, shows unique potential to decipher the mechanisms underlying
phase contrast. Our approach not only aids in understanding changes seen by phase
imaging, but opens a door to better understanding biological underpinnings of MS brain
pathology and has a potential to assist in optimizing design of clinical trials.
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Chapter 7 Conclusions and Future Directions
In this study, we extensively investigated the mechanisms behind gradient echo MRI
signal formation, and explored the use of gradient echo MRI in Multiple Sclerosis. The
origin and use of phase contrast have become hot topics of investigation in the field of
MRI in recent years since it manifests superior gray matter/ white matter contrast and
sub-cortical contrast. By measurement of phase contrast in isolated optic nerve, we have
provided the first direct prove of the theoretical framework – Generalized Lorentzian
Approach – developed in our group. The experiment shows that phase contrast in brain
white matter (optic nerve) is not directly proportional to the tissue bulk magnetic
susceptibility but is rather determined by the geometrical arrangement of brain tissue
components (lipids, proteins, iron, etc.) at the cellular and sub-cellular levels. We have
also provided first quantitative measurements of the contribution to phase contrast from
the water-macromolecule exchange effect. Based on our measurement in protein
solutions, we demonstrated that the magnitude of the exchange effect is 1/2 of
susceptibility effect and to the opposite sign. Further we apply the Generalized
Lorentzian Approach to better understand phase contrasts in MS lesions.

In most of our studies we used Gradient Echo Plural Contrast Imaging (GEPCI)
technique developed in our laboratory. It is based on multi-gradient-echo sequence, and
allows generating of several base and secondary contrasts. Basic contrasts include T2*
relaxation time constant maps, T1-weighted signal intensity images and signal
phase/frequency maps. Secondary contrast images include SWI, T1f, FST2* and T2*SWI. All these base and secondary GEPCI images with multiple novel contrasts provide
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additional information that helps with visualization and identification of brain
abnormalities including MS.

By using GEPCI quantitative T2* maps we have developed a scoring method for
monitoring Multiple Sclerosis. With a cohort of 30 MS subjects (10 in each MS
subtypes), we demonstrated a strong agreement between GEPCI quantitative scores
and traditional lesion load assessment. We also established a correlation between
GEPCI scores and clinical tests for MS patients. We found that this correlation is
stronger than that found between traditional lesion load and clinical tests. We have also
demonstrated the ability of GEPCI scores to distinguish between MS subtypes.

Of course, there are much more in these topics that one can carry on investigating.
1) MS disease. As a CNS disease, the pathology of MS is not restricted in the brain, but
also cerebellum, brain stem, and spinal cord; GEPCI measurement should be
performed on more parts of the CNS in order to reflect more closely to the patients’
clinical status. As demonstrated in our preliminary results (Chapter 5), we have
already started in the direction of spinal cord imaging using GEPCI. Moreover, the
cortical damage is also a very important aspect in evaluating CNS damage, and
remains to be investigated.
2) The GEPCI study needs to be taken to a bigger population in order to allow stronger
statistical power to confirm our preliminary results. Age matched control subjects are
also needed so that we could rule out variations in T2* due to age.
3) Brain atrophy can be added in GEPCI scores as another dimension of abnormality
measurement. It is especially suitable for monitoring longitudinal changes of MS
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subjects under treatment (useful in evaluation of clinical trials).
4) Along the road of using phase contrast in explaining MS lesions in brain white matter
(Chapter 6), it will be important to have histological validation of our theory.
Correlations between pathological hallmarks and MR signal from ex vivo tissue have
been found on T1 and T2 before, and a similar experiment should offer a fairly direct
experimental evidence for origin of phase contrast. However, our data (Chapter 2,
and abstract) show that both magnitude and phase contrast could be very different
from in vivo to formalin fixed tissue – which limits the adequacy of histological
validation. Using animal model in vivo could be a promising solution to this problem.
Marmoset is a good candidate; given it has big WM volume.
5) From technical aspects: to improve GEPCI, one ongoing effort in our group is the
field inhomogeneity correction. Since the quantitative measurement of T2* is actually
susceptible to macroscopic magnetic field inhomogeneity, we always perform careful
shimming on the field before experiments. However, there are some intrinsic sources
of field distortion associated with the brain geometry such as sinuses and ear canals.
A theoretical way to remove field inhomogeneity is under development in our group.
Finally, we treated the gradient echo signal as single compartment throughout the
study, that is we assume the tissue water is uniform in each voxel. In fact, the tissue
water distribution is usually more complicated, and has multiple slow exchanging or
non-exchanging components. Each of them has their own relaxation characteristics,
and their own frequency. The role of multi-compartment model in phase contrast
between gray and white matter; and new insights on relationship between MRI signal
and specific disease pathologies of MS remain to be future directions of our study.
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